Introduction
============

Microorganisms, such as yeasts, bacteria, and algae, are key players in numerous industrial processes, ranging from the production of traditional fermented foods and beverages to recombinant proteins and other high-value molecules.

Many of these industrial processes rely heavily on the model yeast *Saccharomyces cerevisiae*. This yeast is traditionally used in the food industry for the production of alcoholic beverages, such as beer, wine, and sake, as well as for bread fermentation. More recently, *S*. *cerevisiae* has also been used in the bioethanol industry and for the production of heterologous compounds, such as human insulin, hepatitis vaccines, and human papillomavirus vaccines (Hou *et al*., [@b158]). Notwithstanding the fact that *S. cerevisiae* remains by far the most widely used industrial yeast species to date, other, so-called nonconventional yeasts, such as *Scheffersomyces stipitis*, *Yarrowia lipolytica*, *Kluyveromyces lactis*, and *Dekkera bruxellensis*, have also claimed their stake as valuable contributors to industrial fermentation processes.

Despite the intensive use of these and other yeasts in biotechnological applications and industrial fermentations, there is still significant room for improvement: industrial processes are rarely using the most suited or best-performing strain. This is because many industrial strains are currently used because of historical grounds, rather than being carefully selected for a specific application, and are therefore often suboptimal for their purposes. Additionally, demands for increased productivity, wider substrate range utilization, and production of nonconventional compounds in industry, as well as changing consumer preferences, lead to a great interest in further improving the currently used industrial strains and the selection or development of strains with novel properties.

This review aims to give a comprehensive overview of the different strategies that can be used to obtain strains with improved properties. The relevance and importance of these different techniques are illustrated with specific examples from the beer, wine, bread, and biofuel industry. Both the classical approaches of strain improvement and more recent techniques are discussed. In the first section, we discuss natural yeast diversity and the underlying genetic principles and also summarize how the existing natural diversity can be exploited to select strains with a suitable phenotype for a specific industrial application. In the second part, we show how this natural diversity can be further increased by artificially generating variants through mutagenesis, various hybridization methods, and/or directed evolution. Subsequently, the principles of genetic modification are explained, together with specific examples illustrating the applicability of this strategy to food-based fermentations and production of biofuels and high-value chemical compounds. In the final part, we outline several recent advances in genetic modification for the creation of phenotypic variation, illustrating how these cutting-edge techniques combine aspects of traditional technologies with genetic modification and how they could contribute to future improvement strategies for industrial yeasts. Although the major focus of this review is the improvement of the main fermentation workhorse *S. cerevisiae* and its close relatives, such as *Saccharomyces pastorianus*, we also highlight the advances that have been made with other, industrially relevant nonconventional yeasts.

Natural and artificial diversity
================================

Introduction
------------

There are multiple strategies developed that aim to provide suitable yeast strains for specific industrial goals. A deceivingly simple, yet very powerful way is to exploit the natural biodiversity by selecting a strain that performs best in a particular industrial process. Indeed, recent (meta)genomics studies indicate that the natural fungal biodiversity is enormous and largely unexplored, with the current industrial strains only representing a small fraction of the natural biodiversity (Liti *et al*., [@b219]; Wang *et al*., [@b398]). This implies that nature possibly harbors multiple, as yet unknown species and strains that may prove superior for certain industrial fermentations. Even if many of these strains (for various reasons) turn out to be unsuitable for direct industrial implementation, they may possess certain industrially relevant characteristics. Specific strategies could allow transfer of these properties to industrial strains, thereby creating novel yeasts with extra beneficial features (Fig.[1](#fig01){ref-type="fig"}).

![Overview of strategies to obtain superior industrial yeast strains. In order to select novel yeast strains for industrial applications, several strategies can be applied. First, the existing natural diversity can be explored by genotyping and phenotyping isolated feral strains or strains from yeast collections to select the most interesting variants. Apart from investigating naturally occurring yeasts, diversity can also be generated artificially. There are multiple strategies to induce genetic diversity in a single strain or shuffle the genomes of multiple strains. Strains resulting from these strategies are all considered non-genetically modified yeasts, implying that they can be freely used in industrial fermentations. These strategies will be further discussed in the section on 'Generation of artificial diversity'. Lastly, strategies based on genetic engineering, where a recombinant piece of DNA is transformed in a target strain to confer a specific, industrially relevant phenotype to this strain, can be very efficient. However, this technique genetically modifies yeasts, currently limiting their use in food or beverage fermentations because of consumer concerns.](fmr0038-0947-f1){#fig01}

In addition to exploring naturally occurring yeast variants, several techniques allow researchers to further increase the diversity of yeasts by artificially generating variants, starting from feral or industrial strains. The applicability of these techniques depends on both the targeted phenotype and genetic background. The targeted phenotype is sometimes limited by its selectability (cf. infra), while the complex or understudied genetic background of certain yeasts can sometimes hamper their use in improvement strategies. For example, many industrial *S. cerevisiae* strains have a much more complex genetic architecture compared to laboratory strains, the latter being carefully bred and selected for sexual reproduction, optimal growth, and easy handling in the laboratory (e.g. no flocculation) (Mortimer & Johnston, [@b253]), while industrial strains often show aneuploidy and/or polyploidy, poor sporulation efficiency, unstable mating types, etc. Moreover, recent full-genome sequencing and large-scale phenotyping experiments underscore that these 'tamed' laboratory strains are not representative for the majority of industrial strains (Liti *et al*., [@b219]; Borneman *et al*., [@b41]; Warringer *et al*., [@b401]). Together, this implies that although most fundamental studies were performed on easy-to-use laboratory strains, such as S288c or EM93, many of these results cannot be simply extrapolated to industrial strains. Therefore, we also address the potential problems accompanying improvement strategies for genetically complex or understudied yeast strains and species. While this section only focuses on so-called non-genetically modified organisms (non-GMO) techniques to create artificial diversity, the last section will further discuss techniques based on recombinant DNA technologies, such as metabolic engineering and synthetic biology, which generate genetically modified (GM) yeasts.

Before we address examples of how natural or artificially generated diversity can provide industrially relevant strains, we first summarize the genetic mechanisms driving the genetic diversity in yeast. Next, different strategies to yield improved yeast strains are described, pros and cons are discussed, and the challenges associated with the selection of optimal strains are given.

Origins of yeast diversity
--------------------------

Yeasts represent a very diverse group of organisms, and even strains that are classified as the same species often show a high level of genetic divergence. The natural diversity of yeasts (between and even within species) has become very clear with the advent of next-generation sequencing technologies that enable in-depth characterization of the genetic variation (Dujon *et al*., [@b97]; Liti *et al*., [@b219]; Borneman *et al*., [@b41]; Wang *et al*., [@b398]; Borneman *et al*., [@b40]; see section on 'Natural yeast diversity and how it can be exploited in industry').

Genetic variability can be generated by several different processes, including sexual reproduction (where the genomes of two parents are mixed and shuffled), changes in the DNA sequence such as point mutations (i.e. changes in single nucleotides), and InDels (i.e. insertion or deletion events of relatively short pieces of DNA), changes in ploidy level (where a whole genome, or large parts, is duplicated or lost), transposons (mobile genetic elements that can cause mutations by insertion in the genome), genetic recombination (where parts of the genome are re-organized; it can act on both homologous and nonhomologous loci), or acquisition of exogenic pieces of DNA by horizontal gene transfer (HGT) (Fig.[2](#fig02){ref-type="fig"}). Whereas each of these processes described above has been shown to occur in nature and therefore contribute to genetic diversity, the phenotypic outcome and importance of each of these processes is hard to estimate and often also depends on the exact environmental conditions.

![Origins of genetic variation in yeast. Genetic variation can be caused by several different mechanisms. For sake of simplicity, only one chromosome per yeast cell is displayed (green or purple). Different color shades represent homologous chromosomes. In (e), a second chromosome is represented in red. (a) Sexual reproduction: after sporulation and concomitant meiotic cross-over events in the parental strains (2n), genomes of two haploid (n) segregants can hybridize, a process called mating. (b) Point mutations: changes in single nucleotides. These mutations can be synonymous or nonsynonymous: synonymous mutations do not change the amino acid sequence, while nonsynonymous mutations do. Nonsynonymous mutations are therefore more likely to alter the phenotype. (c) InDels: insertion and deletion events of relatively short pieces of DNA. (d) Transposons: insertion of transposable elements in the genome. (e) Changes in ploidy level: the whole genome, or large parts, is duplicated or lost, which can result in poly- or aneuploidies. (f) Horizontal gene transfer: transfer of genes by means other than regular sexual reproduction. (g) Genetic recombination: reorganization of parts of the genome. It can act on both homologous (cross-over and gene conversion) and nonhomologous loci (ectopic recombination). Homologous recombination such as gene conversion (nonreciprocal transfer of genetic material between highly homologous genes) occurs relatively frequently and can sometimes give rise to novel or modified traits. Ectopic recombination events such as TY-promoted chromosomal translocations are more rare, but can drastically rearrange the genome, and even generate novel genes.](fmr0038-0947-f2){#fig02}

Sexual recombination is the single most important process that generates genetic diversity in higher eukaryotes such as animals and plants. Similarly, in yeasts with a sexual life cycle, such as *Saccharomyces* spp., sexual reproduction can reshuffle the genomes of different yeast strains, thereby altering their characteristics, and potentially even lead to the evolution of new species. Although sexual recombination is mostly thought of as a 'natural' process, mating also occurs between strains or species in industrial settings. A notable example is *S. pastorianus*, an interspecific hybrid of *S. cerevisiae* and *Saccharomyces eubayanus*, which may have originated in the fermentation tank of lager breweries (Libkind *et al*., [@b210]). The added advantage of cryotolerance (typical for *S. eubayanus*) may have led to its observed ability to carry out fermentations better at low temperatures than *S. cerevisiae* alone (Dunn & Sherlock, [@b100]).

In contrast to higher eukaryotes, yeasts such as *Saccharomyces* spp. also have the ability to reproduce asexually. Moreover, this vegetative asexual proliferation is a much more prevalent way of reproduction, with on average only one meiotic cycle for every 1000 mitotic divisions (Ruderfer *et al*., [@b322]; Tsai *et al*., [@b376]; Zörgö *et al*., [@b431]). During these asexual reproductive cycles, spontaneous mutations, such as point mutations, InDels, transposon insertions, and recombination events, can occur. The rate at which spontaneous mutations occur varies across the yeast genome, but has been estimated to be around 3.80 × 10^−10^ and 6.44 × 10^−10^/(bp × generation) when measured at two specific loci that allowed for phenotypic detection of mutations (Lang & Murray, [@b202]). However, spontaneous mutations occur much more frequently in so-called mutation hotspots such as subtelomeric regions and tandem repeats (Ellegren, [@b107]; Brown *et al*., [@b45]; Gemayel *et al*., [@b122]; Christiaens *et al*., [@b66]), where the mutation rates are often 10--100 000 times higher than average mutation rates in other parts of the genome (Gemayel *et al*., [@b122]). One particular category of spontaneous mutations which occurs often in these hotspots is genetic recombination. An interesting example of a gene family that is extremely prone to spontaneous mutations, because they are located subtelomerically and additionally contain tandem repeats, are the genes encoding flocculins (*FLO* genes). These flocculins are responsible for 'flocculation' of yeast cells, a trait of major importance in the wine, beer, and biofuel industry. The instability of the tandem repeats in these genes, which are causing expansion and contraction in the gene size, has allowed for the fast isolation of spontaneous mutants with altered flocculation characteristics (Hammond, [@b144]; Verstrepen *et al*., [@b386]; Ma *et al*., [@b232]). Additionally, the available arsenal of flocculins in *Saccharomyces* yeasts is hugely increased by the generation of chimeric *FLO* genes by ectopic recombination, which resulted in a huge diversity in the flocculation phenotype of industrial strains (Christiaens *et al*., [@b66]).

Although spontaneous mutations are one of the main driving forces behind evolution and enable organisms to adapt to specific ecological niches, most mutations are neutral or even deleterious (Drake, [@b94]). Most yeast species (including *S. cerevisiae*) generally exist in a diploid stage, which can mask the effect of (heterozygous) deleterious mutations. This can cause these mutations to accumulate during continuous asexual growth, leading to strains with a high mutational load. However, because of its complex sexual life cycle, yeast can filter out these deleterious mutations by a process called 'genome renewal' (Mortimer *et al*., [@b254]; Mortimer, [@b252]; Wang *et al*., [@b398]). In essence, genome renewal results in the elimination of cells carrying deleterious recessive mutations from the population, while generating homozygous diploid cells in which these mutations are not present. Genome renewal is mainly described for indigenous *Saccharomyces* wine yeasts, which often show a high sporulation capacity and are homothallic (see Fig.[3](#fig03){ref-type="fig"}), two important prerequisites for genome renewal. Asexually growing cells (with a potentially high mutational load) will undergo meiosis and sporulate. After germinating, viable haploids will start reproducing asexually, and subsequently, mating can occur between neighboring 'sister' cells of the opposite mating type (a process called haplo-selfing), yielding a homozygous diploid inbred cell. In this way, the haploid stage filters out lethal recessive mutations and the subsequent haplo-selfing enables recessive, heterozygous mutations to become homozygous and thus influence the phenotype. Intratetrad mating (automixis) after sporulation will have the same effect (Katz Ezov *et al*., [@b182]). Together, this can improve cellular fitness and adaptability to the environment (Pretorius, [@b301]).

![Life cycle of *S. cerevisiae*. Yeast cells can exist in both a haploid and diploid state. (a) Diploid cells are heterozygous for the mating type locus (mating type a/α), which makes diploids incapable of mating. Haploid cells have either mating type a or mating type α, making them capable of mating with a cell of the opposite mating type. In nutrient-rich conditions, both haploid and diploid cells can proliferate asexually by budding. When exposed to some nutrient-poor conditions, diploids can undergo sporulation (meiosis followed by spore formation), resulting in the conversion of a diploid cell into four haploid spores, two possessing mating type a and two having mating type α, which can germinate into haploid cells when conditions improve. In homothallic strains, the haploid derivatives can undergo a mating type switch (together with the mother cell), mediated by an endonuclease encoded by the *HO* gene. In this way, a mating type-switched cell can mate with neighboring sister cells of the opposite mating type, resulting in a homozygous (except for the *MAT* locus, which determines the mating type) diploid. In heterothallic strains, the *HO* gene is typically inactive and therefore haploid derivatives cannot switch mating type. (b) Mechanism of the mating type switch of homothallic strains. On chromosome III, the *MAT* locus is flanked by *Hidden MAT Left* and *Right* (*HML* and *HMR*, respectively), carrying a silenced copy of *MAT*α and *MATa*, respectively. Homothallic strains contain the *HO* gene, a gene coding for an endonuclease that cleaves DNA specifically at the *MAT* locus. After breakdown of the *MAT* locus by exonucleases, a gene conversion event occurs, where *HML* or *HMR* is used as a template to repair the DNA strand. Because cells prefer to change their mating type, that is, a *MAT*α cell will rather use *HMR* as a template and vice versa, mating-type switch occurs frequently.](fmr0038-0947-f3){#fig03}

In addition to sexual recombination and spontaneous mutations, the transfer of genetic material through asexual mechanisms, called horizontal gene transfer (HGT), can contribute to genetic diversity. HGT is rare in yeast, and the mechanisms underlying HGT are not yet elucidated, but natural transformation and conjugation have been proposed (Hall *et al*., [@b140]). An interesting example of how HGT altered industrially relevant phenotypes in yeast is described for the commonly used wine strain EC1118. Genetic analysis of EC1118 showed strong evidence for the HGT of three DNA regions, encompassing 34 genes involved in key wine fermentation functions (Novo *et al*., [@b271]). For example, *FSY1*, a gene coding for a high-affinity fructose/H^+^ symporter present in one of the regions, could confer a significant advantage during the wine fermentation process by enabling the yeast to efficiently utilize left-over fructose at the end of the fermentation (Galeote *et al*., [@b120]). Interestingly, two of these regions were acquired from non-*Saccharomyces* species, and *Zygosaccharomyces bailii*, a typical contaminant of wine fermentations, was identified as the donor of one region; indicating that HGT in yeast can cross genus boundaries.

Lastly, changes in ploidy level also occur and can have profound phenotypic effects. This is best described for the *Saccharomyces* lineage, which has undergone a whole-genome duplication (WGD) event about 100 million years ago. The most important consequences of this WGD are that an extra copy of the genome allowed a global rewiring of the yeast transcriptional network and gave the duplicated genes a chance to mutate and gain new or adapted functions compared to the original genes (reviewed by Piskur *et al.,* [@b298]). Additionally, duplication of single genes pre- or post-WGD, such as the duplication of the alcohol dehydrogenase (*ADH*) gene approx. 80 million years ago, also contributed to the success of *Saccharomyces* species in the fermentation industry. In the case of *ADH*, reconstruction of the ancestral gene revealed that the encoding enzyme had a preference to convert acetaldehyde to ethanol and was therefore involved in the generation, and not the consumption, of ethanol (Thomson *et al*., [@b372]). Spontaneous duplication of this ancestral gene generated the genes encoding the Adh1 and Adh2 enzymes. These present-day enzymes show a different kinetic behavior, with Adh2 binding ethanol (its substrate) more strongly than Adh1. Duplication of the ancestral *ADH* gene as well as duplication of several other genes involved in ethanol metabolism, combined with the ability of *Saccharomyces* spp. to ferment glucose and accumulate ethanol even in the presence of oxygen (a phenomenon known as the Crabtree effect), resulted in the so-called make-accumulate-consume strategy of ethanol production, giving them a competitive advantage over other microorganisms during fermentation processes (Piskur *et al*., [@b298]).

Natural yeast diversity and how it can be exploited in industry
---------------------------------------------------------------

Although the basic principles underlying genetic variation are known (cf. supra), the extent of genetic biodiversity in *Saccharomyces* strains has only recently been elucidated. Two recent seminal papers provided a first comprehensive overview of the genetic architecture of feral (wild) and industrial *Saccharomyces* strains (Liti *et al*., [@b219]; Schacherer *et al*., [@b336]). Interestingly, genetic diversity within *Saccharomyces paradoxus*, a widespread feral species closely related to *S. cerevisiae*, can almost completely be explained by geographical origin. However, diversity within *S. cerevisiae*, the main yeast associated with human activity, was at least partly linked to its industrial application (Legras *et al*., [@b207]; Dunn & Sherlock, [@b100]; Liti *et al*., [@b219]; Schacherer *et al*., [@b336]).

Additionally, despite that it was generally believed that *S. cerevisiae* was a domesticated species with no truly natural strains existing, it was recently shown that diverged populations of wild *S. cerevisiae* exist independently of domesticated isolates (Fay & Benavides, [@b114]; Liti *et al*., [@b219]; Sicard & Legras, [@b345]; Wang *et al*., [@b398]). Moreover, genetic analysis of these feral and industrial strains revealed that the genetic diversity within industrial strains is rather limited compared to the full spectrum of natural biodiversity. For example, while the nucleotide diversity (π, the average number of nucleotide differences per site between any two DNA sequences chosen randomly from the sample population) was calculated to be 0.56 × 10^−3^ in 14 representative wine yeasts, a more elaborate analysis of 138 strains, including both industrial and feral strains, revealed a sequence diversity that was more than one order of magnitude larger (7.27 × 10^−3^) (Wang *et al*., [@b398]). It is important to note that this is truly remarkable, because the nucleotide diversity within *Homo sapiens* is estimated to be 'only' 1 × 10^−3^ (Jorde & Wooding, [@b179]). Furthermore, even the genetic diversity within geographically isolated feral *S. cerevisiae* populations can be substantial, illustrated by the fact that isolates from the primeval rainforests in Hainan, a tropical island in southern China, exhibited a magnitude of genetic diversity equivalent to the diversity of the complete human population (Wang *et al*., [@b398]). Together, these observations suggest that the fermentation industry currently relies on only a very small fraction of the available genetic diversity of *S. cerevisiae*, ignoring a huge pool of unexplored (feral) strains. Although currently used strains have adapted well to the fermentation environment, this largely uncharted yeast pool might contain strains with characteristics potentially valuable for industrial applications.

To exploit this huge natural diversity, several teams have screened diverse feral yeast collections for industrially relevant traits (e.g. Pellegrini *et al*., [@b290]; Comitini *et al*., [@b74]). Additionally, isolation and analysis of feral or even contaminating yeast strains from niches similar (or identical) to a specific fermentation environment can yield interesting strains for starter cultures. Indeed, continuous evolution and adaptation of indigenous yeast strains to their environment have equipped these strains with phenotypes valuable for industry. For example, several research papers have described the isolation, selection, and incorporation of indigenous wine yeasts as starter cultures in the production of wine (Zagorc *et al*., [@b418]; Mannazzu *et al*., [@b238]; Lopes *et al*., [@b224]; Tosi *et al*., [@b374]; Capece *et al*., [@b57]; de Ullivarri *et al*., [@b88]; Scacco *et al*., [@b334]; Tristezza *et al*., [@b375]). Similarly, the application of indigenous yeast strains revolutionized the biofuel industry, where the initially used baker\'s strains were replaced by 'contaminating' strains, which were well adapted to the harsh fermentation environment (Basso *et al*., [@b23], [@b22]; da Silva-Filho *et al*., [@b81]). Moreover, two recently isolated *S. cerevisiae* strains are now responsible for up to 70% of the total Brazilian biofuel production (Basso *et al*., [@b22]; Della-Bianca *et al*., [@b89]). Likewise, the identification of *Dekkera bruxellensis* as a contaminating yeast in a Swedish bioethanol production site has raised interest in applying this species as a starter culture, because this strain did not show a compromised fermentation efficiency and exhibited a more energy-efficient metabolism under oxygen limitation than the initially applied *S. cerevisiae* starter culture (Passoth *et al*., [@b287]; Blomqvist *et al*., [@b36]).

Generation of artificial diversity
----------------------------------

Despite the immense wealth of natural yeast diversity, the extremely selective and specific conditions of industrial fermentations sometimes require (a combination of) phenotypic traits that might not be commonly encountered in nature. While the physiological behavior of feral yeasts is exclusively dedicated to survival and reproduction, most industrial fermentations require maximization of processes and characteristics that may not be beneficial in natural environments. Several techniques have therefore been developed to artificially increase the existing yeast diversity and generate variants that may perform better in industrial settings than the strains that are selected in natural environments.

Perhaps the most intuitive way to generate artificial diversity in yeasts is by (human-driven) sexual hybridization (also known as crossing or mating; Tables[1](#tbl1){ref-type="table"} and S1). This practice is very similar to the common 'selective breeding' (or 'artificial selection') encountered in, for example, agriculture. This technique has been used by humans for thousands of years, for example by farmers who intuitively chose superior plants from their cultivations or animals from their stock to crossbreed in order to obtain crops or livestock with desired traits (Chambers *et al*., [@b63]; Steensels *et al*., [@b356]). Similarly, the close association of *S. cerevisiae* with human activities has led to the so-called domestication of this species, resulting in an organism that excels in its industrial task, but performs suboptimal in most other, more 'natural' environments (Fay & Benavides, [@b114]; Liti *et al*., [@b219]; Sicard & Legras, [@b345]). Moreover, human selection may even have given rise to new chimeric species in the *Saccharomyces sensu stricto* complex in industrial environments, such as the lager yeast *S. pastorianus* (Libkind *et al*., [@b210]). Although these processes occurred naturally (brewers, winemakers, or other craftsmen did not intentionally breed novel yeast strains), recent technological advances and the rapidly increasing knowledge about yeast physiology (e.g. the description of its sexual life cycle) paved the way for more targeted and large-scale approaches of yeast breeding, even beyond species barriers. This targeted breeding of yeast strains can now be used to create novel strains that combine different characteristics of the selected parents, or to optimize a single, often complex, trait, by crossing parents selected for the same phenotype. Using the latter approach, traits can theoretically be improved even beyond the phenotypic boundaries of the parental strains, a phenomenon called heterosis, or hybrid vigor (Lippman & Zamir, [@b217]). This phenomenon is occasionally encountered for certain traits in breeding experiments (Marullo *et al*., [@b240]; Timberlake *et al*., [@b373]), but the incidence is generally low (Zörgö *et al*., [@b431]). Later in this section, four approaches for strain improvement using sexual hybridization approaches will be discussed: direct mating, rare mating, mass mating, and genome shuffling.

###### 

Several key studies using hybridization techniques for the improvement of industrial yeasts. The phenotypes of interest from both parental strains are indicated. For a more extensive list, see [Table S1](#sd1){ref-type="supplementary-material"}

  Parental strain 1                                                   Parental strain 2                                 Hybridization technique                        Industrial application     References
  --------------------------------------------------------------- --- ------------------------------------------------- ---------------------------------------------- -------------------------- -----------------------------------
  **Intraspecific hybridization**                                                                                                                                                                 
   *S*. *cerevisiae*                                              x   *S*. *cerevisiae*                                 Protoplast fusion                              Biofuel                    Javadekar *et al*. ([@b171])
   Fermentation performance                                           Flocculation                                                                                                                
   *S*. *cerevisiae*                                              x   *S*. *cerevisiae*                                 Cytoduction                                    Beer                       Hammond & Eckersley ([@b146])
   Fermentation performance                                           Killer phenotype                                                                                                            
   *S*. *cerevisiae*                                              x   *S*. *cerevisiae*                                 Rare mating                                    Bread                      Oda & Ouchi ([@b272])
   Fermentation performance                                           Fermentation performance                                                                                                    
   *S*. *cerevisiae*                                              x   *S*. *cerevisiae*                                 Spore-to-cell mating                           Biofuel                    Benjaphokee *et al*. ([@b28])
   Temperature tolerance                                              Ethanol tolerance                                                                                                           
  **Interspecific hybridization**                                                                                                                                                                 
   *S*. *cerevisiae*                                              x   *S*. *cerevisiae (*var. *diastaticus)*            Rare mating                                    Beer                       Tubb *et al*. ([@b377])
   Fermentation performance                                           Dextrin degradation                                                                                                         
   *S*. *cerevisiae*                                              x   *S*. *mikitae/S*. *paradoxus/S*. *kudriavzevii*   Rare mating                                    Wine                       Bellon *et al*. ([@b27], [@b26])
   Fermentation performance                                           Flavor profile                                                                                                              
   *S*. *cerevisiae*                                              x   *S*. *bayanus*                                    Protoplast fusion                              Biofuel                    Choi *et al*. ([@b65])
   Ethanol tolerance                                                  Flocculation                                                                                                                
   *S*. *cerevisiae* Fermentation performance                     x   *S*. *kudravzevii* Low temperature                Spore-to-spore/rare mating/protoplast;fusion   Wine                       Perez-Traves *et al*. ([@b293])
   *S*. *cerevisiae*                                              x   *S*. *bayanus*                                    Spore-to-spore mating                          Wine                       Coloretti *et al*. ([@b73])
   Flocculation                                                       Fermentation performance                                                                                                    
  **Intergeneric hybridization**                                                                                                                                                                  
   *S*. *cerevisiae*                                              x   *K*. *lactis*                                     Protoplast fusion                              Biofuel                    Taya *et al*. ([@b369])
   Fermentation performance                                           Lactose utilization                                                                                                         
   *S*. *cerevisiae* Fermentation performance/ethanol tolerance   x   *Sc*. *stipitis* Xylose utilization               Protoplast fusion and genome shuffling         Biofuel                    Zhang & Geng ([@b423])
   *S*. *cerevisiae*                                              x   *T*. *delbrueckii*                                Protoplast fusion                              Polyol production/bakery   Lucca *et al*. ([@b230], [@b229])
   Fermentation performance                                           Osmotolerance                                                                                                               
   *S*. *cerevisiae*                                              x   *Sc*. *pombe*                                     Protoplast fusion                              Wine                       Carrau *et al*. ([@b58])
   Fermentation performance                                           Malic acid degradation                                                                                                      
   *S*. *cerevisiae (var. diastaticus)*                           x   *Z*. *rouxii*                                     Protoplast fusion                              Bakery                     Spencer *et al*. ([@b353])
   Fermentation performance                                           Osmotolerance                                                                                                               

*K*. *lactis*, *Kluyveromyces lactis*; *S*. *bayanus*, *Saccharomyces bayanus*; *S*. *cerevisiae*, *Saccharomyces cerevisiae*; *S*. *cerevisiae* (var. *diastaticus*), *Saccharomyces cerevisiae* (var. *diastaticus*); *S*. *kudravzevii*, *Saccharomyces kudravzevii*; *S*. *mikitae*, *Saccharomyces mikitae*; *S*. *paradoxus*, *Saccharomyces paradoxus*; *Sc*. *pombe*, *Schizosaccharomyces pombe*; *Sc*. *stipitis*, *Scheffersomyces stipitis*; *T*. *delbrueckii*, *Torulaspora delbrueckii*; *Z*. *rouxii*, *Zygosaccharomyces rouxii*.

However, because many industrial strains are, in contrary to most laboratory strains, polyploid or aneuploid and display a low sporulation efficiency and/or low spore viability (Mortimer *et al*., [@b254]; Codon *et al*., [@b72]), strain improvement by sexual hybridization is not always possible. Still, the unique features of yeast (such as its exceptional life cycle that combines sexual and asexual replication strategies (Fig.[3](#fig03){ref-type="fig"}) and their short generation time) facilitate several other strain improvement strategies. For example, a hybridization technique referred to as protoplast (or spheroplast) fusion was designed to hybridize cells asexually, thereby fully precluding the need for sporulation capacity of and sexual compatibility between both parental strains. Additionally, the transfer of non-Mendelian traits, caused by cytoplasmic factors such as dsRNA virus-like particles or prions, without compromising the genome structure of the parental cells, can be accomplished by cytoduction. These techniques, all aiming to combine traits from two parental strains by hybridization, are summarized in Fig.[4](#fig04){ref-type="fig"}. Other techniques, such as mutagenesis and directed evolution, use the asexual reproductive cycle of yeast and fully rely on random genetic mutations and strict selection procedures to isolate phenotypically improved variants. This section provides a comprehensive overview of all these techniques, which do not rely on recombinant DNA technology and for which resulting strains are thus considered non-GMO, and discusses their practical applicability, advantages, and limitations. Additionally, specific examples indicating how industrial fermentation processes have benefited from the resulting improved strains are given.

![Overview of different strain improvement techniques using hybridization. Sexual and asexual hybridization is a powerful technique to generate artificial diversity in yeast. Due to the sometimes complex genetics (ploidy, sporulation, ...) of yeast, different techniques have been developed. Most techniques start from two parental (P) strains, selected for the target phenotype. The color scheme indicates the strength of the phenotype, for example red = strong ethanol tolerance, yellow = weak ethanol tolerance. In these examples, the parental strains are selected for the same phenotype, but combining different phenotypes of both parents is also possible. (a) In direct mating, two haploid cells or spores of opposite mating types are crossed. When the parental strains are both heterothallic, these haploids can be prescreened and selected, and cell-to-cell mating can be applied. When both or one of the parental strains is homothallic, spore-to-spore or spore-to-cell mating, respectively, can be used. In these latter cases, the selection step (indicated with \*) cannot be applied. (b) In rare mating, strains are crossed without a sporulation step. This is possible because diploid yeasts occasionally (but rarely) undergo a homothallic mating-type switch, yielding an a/a or α/α diploid cell. These cells can subsequently hybridize with a haploid cell of the opposite mating type. It is important to note that rare mating is not limited to the development of triploid yeasts. For example, tetraploid hybrids can be obtained if P2 would be an a/a type yeast. (c) In mass mating, multiple parental strains, or a heterogeneous population of the same parental strain, can be used. After mass sporulation and mixing of the resulting spores, mass mating will occur. These rounds of mass sporulation and mass mating can be repeated multiple times, a process which is one way to perform so-called genome shuffling. In genome shuffling, the mass sporulation and mass mating steps can also be replaced by protoplast fusion. (d) Cytoduction can be used to transfer cytoplasmically inherited traits. First, the *KAR1* gene of the parental strain containing the targeted cytoplasmic trait is deleted. Next, both parental strains are crossed (or fused by protoplast fusion), but because karyogamy is blocked, the heterokaryon segregates into cells containing a nucleus of only one parent but the cytoplasmic components of both parents (=heteroplasmons). With proper selection, this technique can also yield so-called disomic strains that contain the full chromosome complement of one parent plus one chromosome from the other parent. (e) In protoplast fusion, cells are asexually merged after cell wall removal in osmotically supportive medium. After cell wall regeneration, the formed transient heterokaryons may undergo karyogamy and form hybrids.](fmr0038-0947-f4){#fig04}

### Direct mating

Direct mating is the most intuitive way of breeding organisms. Similar to selective breeding in agriculture, it consists of the crossing of two carefully selected parents possessing an interesting phenotype. In case of yeast strains, three distinct approaches exist: cell-to-cell, spore-to-cell, and spore-to-spore mating. The applicability of these approaches depends on the sexual cycle of the parental strains.

If both parental strains are heterothallic (Fig.[3](#fig03){ref-type="fig"}b), a prescreening of the stable vegetative haploid segregants of both parents can be carried out, after which the best haploid segregants can be selected for the hybridization experiment. This technique dates back to 1943, when it was described in a seminal paper by Lindegren & Lindegren ([@b216]), and is now called 'cell-to-cell' mating. By simply mixing cell cultures of the two selected stable haploid parents and subsequent screening for diploid cells, hybrids can be isolated. The major advantage of cell-to-cell over mass and spore-to-spore mating (cf. infra) is that both haploid parents can be fully phenotyped prior to the breeding experiment (Lindegren, [@b215]), which increases the chance of yielding a superior hybrid. Additionally, no inbreeding can occur, because no cells of the opposite mating type from the same parental strain are present in the same experiment. Furthermore, the same parent can be used many times in a variety of different mating experiments and can theoretically be preserved indefinitely (Lindegren, [@b215]). Although there are some clear advantages to this approach, it is not used regularly to develop novel yeast hybrids. This is mainly due to the homothallic nature of most industrial and feral yeast strains, making them unsuited for this approach. However, it was recently described that several feral strains show a stable haploid mating type, due to a mutation in the *HO* endonuclease gene, a gene responsible for mating-type switching (Katz Ezov *et al*., [@b182]), making these strains fit for cell-to-cell mating experiments. In principle, also homothallic strains would be amenable to this approach after genetically disrupting the *HO* endonuclease gene (van Zyl *et al*., [@b383]; Walker *et al*., [@b394]; Blasco *et al*., [@b34]; Fig.[3](#fig03){ref-type="fig"}). However, this requires a genetic transformation, which implies that the resulting hybrid is classified as a GMO and is therefore subject to the GMO legislation. In addition, due to the heterozygous nature of many industrial strains, for some complex phenotypes that are difficult to measure, it can be laborious to identify a haploid descendant that exactly recapitulates the parental phenotype.

When one ('spore-to-cell' mating) or both ('spore-to-spore' mating) parental strains are homothallic, no stable haploid segregants can be obtained, and the additional prescreening step is not feasible. However, direct mating is still possible by placing two single spores of the strains to be hybridized close to one another on an agar surface, monitoring the hybridization event by microscopy, and isolating the developed zygotes (which can be formed if the spores are of the opposite mating type) using a micromanipulator. This approach is preferred when both parental strains are homothallic or when the hybridization efficiency of the two parental strains (outcrossing) is low compared to the hybridization efficiency of cells of the same parent (inbreeding) and no suitable hybrid selection markers are available to specifically isolate outbreds. The latter is, for example, the case in some interspecific crossing experiments, where the (however weak) pre- and postzygotic barriers (such as differences in germination timing or mating preferences) favor inbreeding (Maclean & Greig, [@b234]; Morales & Dujon, [@b250]; Murphy & Zeyl, [@b255]). In this case, spore-to-spore mating (instead of, e.g., mass mating) can be used to promote outcrossing. A major disadvantage of spore-to-spore compared to cell-to-cell mating is that the spores used in the experiment cannot be characterized prior to the mating and therefore might not display the desired phenotype of the parental strain, due to the segregation of causative alleles (Attfield & Bell, [@b12]). An additional step that can increase the frequency of developing hybrids with the desired phenotype is a phenotypic prescreening of the self-mated homozygous diploids formed after sporulation and tetrad dissection of the homothallic parental strains (Romano *et al*., [@b314]; Marullo *et al*., [@b241]), or use of a well-designed backcrossing scheme (Marullo *et al*., [@b241]).

Although time-consuming, direct mating has proven to be an effective way to obtain hybrids (Sipiczki, [@b347]); spore-to-spore and spore-to-cell mating are applied regularly to create novel, mainly interspecific hybrids for the fermentation industry (Table[1](#tbl1){ref-type="table"}). It has been used successfully to generate wine yeasts with improved cryotolerance, by crossing *S. cerevisiae* with cryotolerant species such as *S. kudriavzevii* or *S. bayanus* (Kishimoto, [@b190]; Zambonelli *et al*., [@b419]; Perez-Traves *et al*., [@b293]), or to introduce flocculation in a yeast strain for the production of sparkling wines (Coloretti *et al*., [@b73]). Recently, spore-to-cell mating was applied to develop thermotolerant (Marullo *et al*., [@b241]) and multistress-tolerant *S. cerevisiae* strains (Benjaphokee *et al*., [@b28]). Also, novel hybrids with improved characteristics developed by cell-to-cell mating have been reported. Hara *et al*. ([@b148]) used this approach to construct cryotolerant wine yeasts able to produce killer toxins. Russell *et al*. ([@b324]) described the use of cell-to-cell mating to eliminate the unwanted 'phenolic off-flavor' phenotype from brewer\'s yeast. This approach was also used to construct wine, bread, and beer yeasts with optimal fermentation characteristics (Gjermansen & Sigsgaard, [@b130]; Eschenbruch *et al*., [@b112]; Nakagawa & Ouchi, [@b258]; Marullo *et al*., [@b240]). More recently, it was used to combine specific phenotypes of ale and lager yeasts in order to improve stress resistance and fermentation performance (Garcia Sanchez *et al*., [@b121]).

### Rare mating

As mentioned above, many natural and industrial yeasts show low sporulation efficiencies and/or low spore viability, hampering their use in direct mating (or mass mating, cf. infra) experiments. In these cases, rare mating can offer a way to obtain hybrids. Rare mating is based on the rare event that some cells in a diploid population can become homozygous for the mating-type locus (resulting in an a/a or α/α cell) and can subsequently be 'force-mated' with a cell of the opposite mating type (Gunge & Nakatomi, [@b137]), see also Figs[3](#fig03){ref-type="fig"} and [4](#fig04){ref-type="fig"}. Typically, in a rare mating experiment, dense cell suspensions of the parental strains are mixed, and subsequently outcrossed hybrids are isolated using a strong selection step. This selection is often achieved by using a respiratory-deficient and an auxotrophic parental strain, making rare hybrids easily selectable by their prototrophy and respiratory proficiency (Pretorius, [@b301]; Hammond, [@b145]; see 'Selection of outcrossed hybrids').

Although the frequencies of the mating-type switch and subsequent mating are usually very low (Gunge & Nakatomi, [@b137]; Hammond, [@b145]), rare mating has been used to study interspecific hybridization events (de Barros Lopes *et al*., [@b84]) as well as for the improvement of multiple yeast traits. *Saccharomyces cerevisiae* and *S. cerevisiae* (var. *diastaticus*) were crossed to develop yeasts able to ferment dextrins (low molecular weight carbohydrates, produced by the hydrolysis of starch) in order to produce low-calorie beers (Tubb *et al*., [@b377]). It has also been applied to construct cryotolerant wine yeasts (Perez-Traves *et al*., [@b293]), dextrin-fermenting and high ethanol-producing yeasts (Kim & Kim, [@b188]), and yeasts with higher leavening ability in dough fermentations (Oda & Ouchi, [@b272]). Recently, Bellon and coworkers used rare mating to construct triploid interspecific hybrids of *S. cerevisiae* and other *Saccharomyces sensu stricto* species (like *Saccharomyces mikatae*) to diversify the flavor profile of wines (Bellon *et al*., [@b27], [@b26]).

### Mass mating and genome shuffling

Because yeasts are such small organisms with short life cycles, it is possible to cultivate billions of individual cells and generate many crosses quickly and to execute consecutive rounds of crossing. These more evolved techniques, often referred to as 'mass mating' or 'genome shuffling', can significantly increase the throughput and thus success rate of the experiment. Mass mating is a technique in which large numbers of haploid yeast cells, often from different parental strains are mixed and allowed to randomly mate. Mass mating is a particularly useful improvement technique for homothallic strains, for strains that show low mating efficiency, or for the creation of interspecific hybrids if strong selective markers for outbreds are available (Kunicka-Styczynska & Rajkowska, [@b198]).

Mass mating has been used to generate industrial strains with improved characteristics. For instance, Higgins and coworkers used mass mating and selection to combine different properties of two types of bakery strains, namely high osmotolerance, which is typical for strains used in sweet dough, and good maltose utilization, a characteristic of strains used in unsugared dough. First, haploid segregants of seven industrial strains used in sweetened dough were mass-mated followed by selection for osmotolerance, and this procedure was repeated several times. Second, three strains used for unsugared dough fermentations were subjected to repeated cycles of mass mating and selection for growth on maltose. In a final step, the two enriched populations were sporulated and mass-mated, and strains capable of leavening both sweet and unsugared dough were recovered after additional rounds of mass mating and alternating selection for osmotolerance and growth on maltose (Higgins *et al*., [@b151]). Mass mating was also used to create new interspecific wine strains by crossing strains of *S. cerevisiae* and *S. bayanus* (Sato *et al*., [@b332]; Table[1](#tbl1){ref-type="table"}).

Conceptually related to mass mating, genome shuffling is one of the most recent techniques to improve complex phenotypes in microorganisms in a fast and relatively easy manner (see Gong *et al*., [@b133]). In a heterogeneous population, a cell displaying a specific phenotype might harbor beneficial mutations that differ from those present in another, phenotypically similar cell within this population. By applying repeated rounds of genetic recombination (either by protoplast fusion or by mass mating) and selection to this population, genome shuffling aims to combine many of these different beneficial mutations in the same cell, leading to additive or synergistic effects on the phenotype under study (Santos & Stephanopoulos, [@b331]).

Compared to other improvement techniques, genome shuffling has the advantage of exploiting the full genetic diversity in a population and makes it possible to combine useful mutations from many different individuals, while other hybridization methods, such as direct mating, typically involve only a limited number of haploid cells (Fig.[4](#fig04){ref-type="fig"}). Additionally, while classical methods of strain improvement often only select the best-performing mutant for the next round, genome shuffling exploits a much larger proportion of the diversity present in the population. The first convincing example of genome shuffling showed rapid improvement of tylosin production in the bacterium *Streptomyces fradiae* (Zhang *et al*., [@b424]). While it initially took 20 rounds of mutagenesis and selection to improve the tylosin titer ninefold, the same result was obtained by applying only two rounds of genome shuffling on a mutagenized population of the same starting strain, demonstrating the potential of this technique to take much larger leaps in the fitness landscape, enabling rapid improvement of a phenotype.

Most studies applying genome shuffling to yeast have focused on enhancing the tolerance to an industrially relevant stress factor and overall fermentation performance. To this end, variation is typically induced by mutagenizing a single strain. Mutants are then screened for the phenotype of interest, and cells showing phenotypic improvement are used as a starting population for multiple rounds of genome shuffling. After each round of genome shuffling, the severity of the stress is (usually) increased. In this way, both laboratory and industrial strains of *S. cerevisiae* have been improved for phenotypes such as ethanol tolerance, thermotolerance, acetic acid tolerance, and fermentation performance (Table[2](#tbl2){ref-type="table"}). Some recent studies also combine metabolic engineering with genome shuffling (Wang & Hou, [@b396]; Jingping *et al*., [@b176]; Tao *et al*., [@b368]; Wang *et al*., [@b397]; Demeke *et al*., [@b91]). These approaches are promising to optimize strains for second-generation bioethanol production. Although the production of inferior, so-called crippled strains (cf. infra) is a potential disadvantage of genome shuffling because the prevalence of deleterious alleles may result in a majority of variants that perform better at the task they are selected for, but not other important traits, the first proof-of-principle use of a genome-shuffled *S. cerevisiae* strain in an industrial fermentation environment was recently published (Zheng *et al*., [@b426], [@b427]).

###### 

Studies using genome shuffling for the improvement of industrial yeasts. The phenotypes of interest from the parental strain(s) are indicated. The technique used to generate genetic variation and used for recombination is indicated

  Strain(s)                                        Phenotype                                             Technique variation                 Recombination technique   Industrial application   Reference
  ------------------------------------------------ ----------------------------------------------------- ----------------------------------- ------------------------- ------------------------ -----------------------------
  *S*. *cerevisiae* (industrial haploid)           Ethanol tolerance, thermotolerance                    UV mutagenesis                      Protoplast fusion         Biofuel                  Shi *et al*. ([@b343])
  *S*. *cerevisiae* (laboratory diploid)           Ethanol tolerance                                     EMS mutagenesis                     Mass mating               Biofuel                  Hou ([@b159])
  *S*. *cerevisiae* (industrial diploid)           VHG fermentation capacity                             EMS mutagenesis                     Mass mating               Biofuel/beer             Hou ([@b160])
  *S*. *cerevisiae* (industrial diploid ale)       Wort and ethanol tolerance                            EMS and UV mutagenesis              Mass mating               Beer                     Wang & Hou ([@b396])
  *S. cerevisiae* (industrial diploid biofuel)     Acetic acid tolerance                                 UV mutagenesis                      Mass mating               Biofuel                  Zheng *et al*. ([@b426])
  *S*. *cerevisiae* (industrial strains)           Multistress tolerance                                 Use of two strains                  Mass mating               Biofuel                  Zheng *et al*. ([@b427])
  *S*. *cerevisiae* (laboratory diploid)           VHG fermentation capacity                             EMS mutagenesis                     Mass mating               Biofuel/beer             Liu *et al*. ([@b221])
  *S*. *cerevisiae* (industrial haploid strains)   Spent sulfite liquor tolerance                        UV mutagenesis                      Mass mating               Biofuel                  Pinel *et al*. ([@b297])
  *S*. *cerevisiae* (diploid soil isolate + GMO)   Ethanol production                                    Use of multiple strains             Protoplast fusion         Biofuel                  Jingping *et al*. ([@b176])
  *S. cerevisiae* (industrial strain)              Heat, acetic acid, and furfural tolerance             DES mutagenesis                     Protoplast fusion         Biofuel                  Lu *et al*. ([@b228])
  *S*. *cerevisiae* (industrial strain)            VHG fermentation capacity                             GMO strain                          Mass mating               Biofuel                  Tao *et al*. ([@b368])
  *S*. *cerevisiae* (industrial strain)            VHG fermentation capacity                             GMO strain and EMS/UV mutagenesis   Mass mating               Biofuel                  Wang *et al*. ([@b397])
  *S. cerevisiae* (industrial near triploid)       VHG fermentation capacity                             MCB mutagenesis                     Mass mating               Biofuel                  Zheng *et al*. ([@b428])
  *S. cerevisiae* (industrial near triploid)       VHG fermentation capacity and dessication tolerance   MCB mutagenesis                     Mass mating               Biofuel                  Zheng *et al*. ([@b429])
  *S*. *cerevisiae* (industrial strain)            Xylose fermentation                                   GMO strain and EMS mutagenesis      Mass mating               Biofuel                  Demeke *et al*. ([@b91])
  *Z*. *rouxii* (wild-type strain)                 Salt tolerance                                        EMS mutagenesis                     Protoplast fusion         Soy sauce                Cao *et al*. ([@b56])
  *H*. *anomala* (wild-type strain)                Salt tolerance                                        EMS and UV mutagenesis              Protoplast fusion         Soy sauce                Cao *et al*. ([@b55])
  *Sc*. *stipitis* (wild-type strain)              Spent sulfite liquor tolerance                        UV mutagenesis                      Mass mating               Biofuel                  Bajwa *et al*. ([@b18])
  *C*. *krusei*                                    Acetic acid tolerance                                 UV mutagenesis                      Protoplast fusion         Biofuel                  Wei *et al*. ([@b403])

*C*. *krusei*, *Candida krusei*; *H*. *anomala*, *Hansenula anomala*; *S*. *cerevisiae*, *Saccharomyces cerevisiae*; *Sc*. *stipitis*, *Scheffersomyces stipitis*; *Z*. *rouxii*, *Zygosaccharomyces rouxii*; DES, diethylsulfate; EMS, ethyl methane sulfonate; GMO, genetically modified organism; UV, ultraviolet; MCB, methyl benzimidazole-2-yl-carbamate; VHG, very high gravity.

Genome shuffling has been applied to non-*Saccharomyces* yeasts as well. In high-salt soy sauce fermentations, salt-tolerant yeast strains are added for improved flavor. Cao *et al*. ([@b56]) enhanced salt stress resistance and flavor formation of *Zygosaccharomyces rouxii* using three rounds of genome shuffling. In a similar approach, Cao *et al*. ([@b55]) could increase the salt stress tolerance and soy sauce fermentation performance of *Hansenula anomala*. Bajwa *et al*. ([@b18]) exploited the sexual cycle of the pentose-fermenting yeast *Sc. stipitis* to improve its tolerance to hardwood spent sulfite liquor. Lastly, the acetic acid tolerance of *Candida krusei* was improved using a protoplast fusion-based genome shuffling strategy (Wei *et al*., [@b403]).

### Protoplast fusion

Although the rationale for protoplast fusion (often referred to as spheroplast fusion) is very similar to sexual hybridization (they both strive to combine positive traits of multiple parents in one hybrid strain), this technique can be used for strains that do not meet the requirements for sexual hybridization. This means that this technique is useful for strains that cannot sporulate, yield inviable spores, show unstable mating type or for strains that are incapable to mate with each other (Pretorius, [@b301]; Attfield & Bell, [@b12]), see also Fig.[4](#fig04){ref-type="fig"}. In this way, interspecific or even intergeneric crosses can be obtained. Because meiosis is not required, protoplast fusion can also be used to increase the ploidy of strains, which in some cases can increase cell productivity (Attfield & Bell, [@b12]).

In practice, protoplast fusion generally consists of three major steps: yeast cell wall degradation (generation of protoplasts), induction of hybridization, and cell wall regeneration. After hybridization, the parental nuclei temporarily coexist within a shared cytoplasm before (potentially) proceeding to karyogamy (Kavanagh & Whittaker, [@b183]). The success rate of the hybrid formation mainly depends on the taxonomic proximity of the strains and applied fusion protocol (Peberdy, [@b288]; Pina *et al*., [@b296]; Kavanagh & Whittaker, [@b183]; Attfield & Bell, [@b12]). Intraspecific fusion frequencies usually vary from 10^−3^ to 10^−4^, while for intergeneric fusions, it can be as low as 10^−6^ to 10^−7^ (Pina *et al*., [@b296]; Urano *et al*., [@b379]). Consequently, development of an optimal hybrid selection procedure is a crucial step in order to maximize the chance of achieving the desired genetic combination (further discussed in 'Selection of outcrossed hybrids').

An important disadvantage of using protoplast fusion as a strain improvement strategy is that many of the hybrids are mitotically unstable and chromosomal loss (resulting in aneuploidy) or dissociation into the parental strains often occurs (Pina *et al*., [@b296]; Attfield & Bell, [@b12]). Distantly related species are more prone to show this effect than closely related species (Morgan, [@b251]). Generally, protoplast fusion experiments result in hybrids containing the full genome of one parent, with a (few) extra chromosome(s) of the second parent (Yamazaki & Nonomura, [@b410]; Kavanagh & Whittaker, [@b183]). As a consequence, the phenotype and genotype of the resulting fused strain are very difficult to predict. The ratio at which both genomes are present in the hybrid might be a result of the fusion protocol employed, or the selection procedure used to isolate the hybrids (Kavanagh & Whittaker, [@b183]). Additionally, strains obtained by protoplast fusion are in some regions considered GMOs.

Although protoplast fusion is sometimes used in biotechnology to increase productivity of a strain by increasing the ploidy, it is mostly applied to combine characteristics from two parental strains. These parental strains can be from the same species, but often a *Saccharomyces* strain is combined with a nonconventional yeast displaying a specific trait, such as lactose utilization (Taya *et al*., [@b369]; Farahnak *et al*., [@b113]; Krishnamoorthy *et al*., [@b196]; Guo *et al*., [@b139]), temperature tolerance (Sakanaka *et al*., [@b328]), osmotolerance (Spencer *et al*., [@b353]; Loray *et al*., [@b226]; Lucca *et al*., [@b229]), starch degradation (Kishida *et al*., [@b189]), killer activity (Gunge & Sakaguchi, [@b138]), malic acid degradation (Carrau *et al*., [@b58]), or (hemi)cellulose hydrolysate utilization (Pina *et al*., [@b296]; Heluane *et al*., [@b150]; Table[1](#tbl1){ref-type="table"}).

Interestingly, protoplast fusion rarely yields nuclear hybrids (Chambers *et al*., [@b63]). While most research addressing protoplast fusion focuses on traits embedded in the genomic DNA, mitochondrial transfer without karyogamy occurs at a much higher frequency. Much like the strains resulting from cytoduction experiments (cf. infra), 'cybrids' can be defined as fusion products in which the cytoplasmic contents of the fusing protoplasts merge, without the concomitant fusion of, or exchange of genetic information between, the nuclei (Kavanagh & Whittaker, [@b183]). This phenomenon has been successfully used for the transfer of cytoplasmically inherited traits like the killer phenotype (Seki *et al*., [@b339]), respiratory competence (Richard *et al*., [@b309]; Kavanagh & Whittaker, [@b183]), or resistance to oligomycin (Matsuoka *et al*., [@b242]).

### Cytoduction

Some factors underlying industrially relevant phenotypes are not embedded in the nuclear DNA, but are located in the mitochondrial DNA (e.g. several respiration-related genes) or present in the cytoplasm (e.g. killer plasmids). To selectively transfer these non-Mendelian traits from a donor to a recipient strain without disrupting the nuclear integrity of the recipient strain, a technique called cytoduction can be applied (Pretorius, [@b301]).

In cytoduction procedures, the donor strain (which contains the cytoplasmically transferable factor) carries a dysfunctional *KAR1* gene. A *kar1* mutant is defective in karyogamy (=nuclear fusion) after hybridization (Conde & Fink, [@b75]; Georgieva & Rothstein, [@b123]). As a consequence, through mating or protoplast fusion of donor and recipient strain, a zygote-like transient heterokaryon is formed which by subsequent mitotic divisions can bud off haploid heteroplasmons, containing only one genome but mixed cytoplasmic factors (Conde & Fink, [@b75]; Fig.[4](#fig04){ref-type="fig"}). These heteroplasmons, which still contain the full, undisrupted genome of the recipient strain but are supplemented with the (desired) cytoplasmic factors of the donor strain, have the desired combined phenotype. Occasionally, one or a few chromosomes of the second parent are transferred to the other nucleus, a process called 'single-chromosome transfer' (Nilsson-Tillgren *et al*., [@b265]; Dutcher, [@b102]). This results in 'exceptional' cytoductants that are sometimes used to examine individual chromosomes of industrial yeast strains in detail, for example chromosome III of lager yeasts (Nilsson-Tillgren *et al*., [@b266]; Kielland-Brandt *et al*., [@b184]).

Cytoduction is frequently used to obtain industrial strains with a positive killer phenotype, a trait encoded by a dsRNA virus-like particle (Ouchi *et al*., [@b278]; Young, [@b415]; Hammond & Eckersley, [@b146]; Seki *et al*., [@b339]; Yoshiuchi *et al*., [@b412]). Alternatively, it can be used to transfer flocculation characteristics (Barre *et al*., [@b20]), factors influencing carbon source utilization (Spencer *et al*., [@b354]) or yeast artificial chromosomes (YACs; Spencer *et al*., [@b352]). Cytoduction is also applied in fundamental research when studying amyloids (e.g. prions) in yeast (Saifitdinova *et al*., [@b326]; Wickner *et al*., [@b404]).

It is important to note that development of *kar1* mutants does require genetic modification, which could hamper the use of this technique for industrial applications.

### Mutagenesis

The *in vivo* induction of random mutations by chemical or physical mutagens and subsequent selection of phenotypically improved cells is one of the most widely used techniques to generate optimized microorganisms. One of the most impressive examples is the enormous increase, estimated to be more than three orders of magnitude, in penicillin production by *Penicillium chrysogenum*, which was achieved over a period of 60 years using multiple mutagenesis procedures (Demain, [@b90]). Over the last decades, mutagenesis has been applied to improve both monogenic and polygenic traits in a wide range of microorganisms (Giudici *et al*., [@b129]). Strain improvement using mutagens consists of two key steps: mutagenesis and screening. The screening is very similar to the screening procedures used in other procedures and will therefore be discussed in a separate paragraph (see section on 'Selection of phenotypically improved cells').

A typical mutagenesis experiment consists of overnight growth of the strain under study followed by the actual mutagenic treatment and a recovery step. Both the type of mutagen (different mutagens induce different types of mutations, see Table[3](#tbl3){ref-type="table"}) and the dose should be carefully selected or determined (see detailed reviews by Rowlands, [@b320]; Crook & Alper, [@b79]). However, it is often hard to predict which type of genetic alteration is required to improve a certain phenotype and hence which mutagen should be used. Therefore, it is advised to change the type of mutagen in a mutagenesis program consisting of multiple rounds, in order to sample as many different types of genetic changes as possible (Rowlands, [@b320]).

###### 

Mutagens often used in mutagenesis programs in yeast. Indicated are the mode of action of the mutagen and the resulting genetic alterations that it can induce. See for more information: Rowlands ([@b320]) & Rubio-Texeira *et al*. ([@b321])

             Mutagen              Mode of action                                                                                                                        Genetic alterations
  ---------- -------------------- ------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------
  Physical   UV                   Mitotic crossing over; mitotic gene conversion; pyrimidine dimers; hydroxylated bases; cross-linking DNA strands; reverse mutations   Frameshift mutations, base pair substitutions, transversions
             Ionizing radiation   Single- and double-strand breaks in DNA; deamination and dehydroxylated bases                                                         Point mutations
  Chemical   EMS                  Alkylation                                                                                                                            GC-AT transitions
             MNNG                 Alkylation, acts close to replication points                                                                                          Transitions, transversions; clustered mutations

EMS, ethyl methanesulfonate; MNNG, methylnitronitrosoguanidine; UV, ultraviolet.

As important as the type of mutagen is the mutagenic dose and exposure time. In general, a very low dose will yield a low proportion of mutants, making improved mutants hard to identify. Moreover, most mutants may only carry one or a few mutations, which reduces the chance to find improvements for which combinations of different mutations are needed. On the other hand, a high dose generates mutants that carry multiple mutations, of which many may be deleterious, leading to a large fraction of inferior or even unviable cells. Consequently, the optimal dose is the one that gives the largest proportion of beneficial mutants out of all cells that manage to survive; something which largely depends on the nature of the phenotype. Simple phenotypes that depend on one or a few mutations, like auxotrophy, typically show a monotonic dose--response curve, meaning that the fraction of desired mutants per survivor increases with increasing dose and reaches saturation at some point, after which the number of superior mutants may decline again because of the increasing proportion of individuals with deleterious mutations (Crook & Alper, [@b79]). For complex phenotypes, like the production of a compound/metabolite in a high concentration, that are influenced by many different genes, the ideal dose and the dose--response curve are harder to predict. Although a high dose will usually lead to fast phenotypic improvement, researchers usually prefer to use a low dosage. In this way, they avoid the accumulation of deleterious mutations and only increase the mutation rate when low killing rates do not yield improved mutants (Rowlands, [@b319]).

In both the wine and brewing industry, early studies applied random mutagenesis to generate mutants with improved industrial characteristics. In wine strain improvement, mutagenesis is often used to purge undesired monogenic traits (Giudici *et al*., [@b129]). Industrial yeast strains are (at least) diploid, implying that only dominant mutations can alter the phenotype directly. Therefore, haploid derivatives are preferred for mutagenesis programs (Pretorius, [@b301]). However, these yeasts are often homothallic, so no stable haploid cell cultures can be maintained for these strains. To circumvent this issue, mutagenesis can be applied to spores (instead of vegetative haploid cells) derived from such homothallic strains (Romano *et al*., [@b313]; Rous *et al*., [@b318]). After autodiploidization, these recessive mutations become homozygous and potentially influence the phenotype. However, it is not essential to use haploid strains or spores in a mutagenesis program. Mutagenesis of polyploid brewing yeasts yielded strains producing lower amount of the off-flavors diacetyl and H~2~S (Molzahn, [@b249]). In a recent study, the commercial diploid wine strain PDM was mutagenized directly using EMS, and mutants with reduced H~2~S production were obtained (Cordente *et al*., [@b76]). Also, sake strains in their natural ploidy were successfully mutagenized to obtain auxotrophic mutants (Hashimoto *et al*., [@b149]), which can be of great value in breeding and metabolic engineering strategies (Crook & Alper, [@b79]). Auxotrophic mutants were also developed by applying EMS mutagenesis to a haploid derivative of a commercial wine strain, in order to decrease higher alcohol production (Rous *et al*., [@b318]). Mobini-Dehkordi *et al*. ([@b247]) used EMS mutagenesis to develop mutants with increased ethanol production. In a different study, EMS was used to develop mutants with increased dough fermentation capacity (Angelov *et al*., [@b10]).

Mutagenesis approaches are not limited to *Saccharomyces* yeasts. For instance, EMS mutagenesis has been used to increase astaxanthin production in *Xanthophyllomyces dendrorhous* (*Phaffia rhodozyma*; Brehm-Stecher & Johnson, [@b43]). Recently, EMS mutagenesis was successfully applied to improve the secretion of a heterologous protein in *Ashbya gossypii* (Ribeiro *et al*., [@b308]). Induced mutants of *Sc. stipitis* for improved lignocellulose fermentation were generated in various studies (Watanabe *et al*., [@b402]; Hughes *et al*., [@b162]), whereas multiple rounds of mutagenesis boosted the ethanol production of *Kluyveromyces marxianus* (Pang *et al*., [@b283]).

In recent studies, mutagenesis is often the first step to generate genetic variation in a population, after which genome shuffling of the best-performing mutants is applied to combine multiple beneficial mutations in the same cell, or the mutant population is subjected to directed evolution (cf. infra). Alternatively, strains obtained by genetic modification or breeding can also be further improved using random mutagenesis. For instance, Kumari & Pramanik ([@b197]) subjected a hybrid between *S. cerevisiae* and *Pachysolen tannophilus* to multiple rounds of mutagenesis in order to increase its tolerance to high temperature, ethanol, and toxic compounds.

### Directed evolution

Strain improvement through evolutionary engineering, a term first coined by Butler *et al*. ([@b49]) and later also often referred to as adaptive, directed, or experimental evolution, relies on the basic principles of (natural and/or induced) genetic variation and subsequent selection acting on this variation. In general, a population of cells is grown under continuous selection for the phenotype of interest for many generations (cell divisions). Over time, random mutants will arise in this population. Directed evolution can also be combined with the use of mutagens and/or sexual hybridization within the evolving population(s) in order to increase the genetic and phenotypic variability that selection can act on. If a specific mutation (or mutations) endows a cell with a fitness advantage, this variant will be selected and enriched for in the population. Because of the short generation time and easy manipulation and cultivation of microorganisms in the laboratory, evolutionary engineering is a feasible route to generate yeast strains with improved phenotypes in a relatively fast fashion (Elena & Lenski, [@b106]; Buckling *et al*., [@b48]).

Different experimental setups can be used for growing cells under the desired selective conditions: batch culture, with serial passaging of cells, or a continuous culture system such as a chemostat or a turbidostat. In a chemostat, cells are kept at physiological steady state, and growth occurs at a constant rate. This constant growth rate is maintained by the continuous influx of a growth-limiting substrate, setting a fixed dilution rate (Dykhuizen & Hartl, [@b103]). In a turbidostat, there is continuous feedback between the inflow of the medium and the cell density of an exponentially growing culture, measured through, for example, an optical sensor (Bryson & Szybalski, [@b47]). In principle, it is also possible to evolve populations directly in the industrial setting where they are to be employed. It is important that the selection conditions match the industrial parameters as closely as possible in order to avoid 'crippled' strains that show improvement for the selected trait, but are inferior to the parent for other relevant traits (cf. infra). In fact, in applications where yeasts are continuously used for longer time periods, for example serial repitching of brewer\'s yeast in beer fermentations (Gibson *et al*., [@b124]), these populations are (unintentionally) being subjected to directed evolution, yielding strains with (sometimes positively) adjusted phenotypes. For example, at the end of the beer fermentation process, yeast cells sediment to the bottom of the fermentation tank. It has been shown that re-using cells from specific layers (near the top or bottom) of this pack of sedimented cells can influence the sedimentation behavior (including flocculation) in later fermentation rounds (Powell *et al*., [@b300]).

Directed evolution has proven to be a valuable tool to create yeast strains with specific, improved characteristics (Sauer, [@b333]). Examples of industrially relevant phenotypes improved through this strategy can be found in Table[4](#tbl4){ref-type="table"}. Several studies have investigated how yeast cells adapt to specific nutrient limitations, for example glucose, phosphate, or sulfate limitation (Paquin & Adams, [@b284], [@b285]; Dunham *et al*., [@b99]; Gresham *et al*., [@b135]). Because the main focus of these studies was to determine the exact genetic underpinnings of how cells adapt to a specific stress and also how reproducible the adaptation was, this research was performed with standard laboratory yeast strains that have only limited industrial relevance. However, several more applied studies have started from strains commonly used in the wine, beer, biofuel, and baking industry. The phenotypes targeted include resistance to individual stresses, such as high levels of acetate (Aarnio *et al*., [@b1]) or ethanol (Brown & Oliver, [@b46]; Dinh *et al*., [@b93]), osmotic stress (Ekberg *et al*., [@b105]), and high concentrations of metal ions such as copper (Adamo *et al*., [@b3]) and cobalt (Cakar *et al*., [@b53]), as well as (improved) utilization of alternative carbon sources such as xylose and arabinose (starting from metabolically engineered strains, see also below; Sonderegger & Sauer, [@b351]; Wisselink *et al*., [@b406]; Scalcinati *et al*., [@b335]; Demeke *et al*., [@b91]). However, in industrial settings, cells are often faced with a combination of different stresses: during brewing fermentations for example, cells encounter osmotic stress, high levels of ethanol, and nutrient deprivation (Gibson *et al*., [@b124]). By performing the selection steps under conditions resembling this harsh environment, researchers have succeeded to isolate multistress-tolerant lager strains with improved fermentation capacity in high-gravity wort (Blieck *et al*., [@b35]; Huuskonen *et al*., [@b164]). Using long-term batch culturing on gluconate, a carbon source poorly assimilated by *S*. *cerevisiae*, Cadière *et al*. evolved a commercially used wine strain with increased flux through the pentose phosphate pathway (Cadière *et al*., [@b50]). Evolved strains showed higher fermentation rates and increased aroma production compared to the parental strain in laboratory-scale fermentations. Interestingly, similar phenotypic improvements were observed when this evolved strain was used in pilot-scale fermentation trials (Cadière *et al*., [@b51]). Most evolutionary engineering studies have been performed using the model organism *S. cerevisiae*, but other yeast species have been subjected to evolutionary engineering as well. Examples include lager strains (*S. pastorianus*), subjected to sequential selection for tolerance to high ethanol levels and rapid growth at high osmolarity, to obtain strains with enhanced fermentation capacity under industrially used brewing conditions (Ekberg *et al*., [@b105]).

###### 

Studies using directed evolution for the improvement of industrial yeasts. The targeted phenotype, target species, and technique used to generate variation in the starting population are indicated

  Improved phenotype                                                 Species                                                      Starting population                        Reference
  ------------------------------------------------------------------ ------------------------------------------------------------ ------------------------------------------ -------------------------------
  Ethanol tolerance                                                  *S*. *uvarum*                                                EMS-mutagenized and nonmutagenized         Brown & Oliver ([@b46])
  *S*. *cerevisiae*                                                  EMS-mutagenized and nonmutagenized                           Dinh *et al*. ([@b93])                     
  *S*. *cerevisiae*                                                  EMS-mutagenized and nonmutagenized                           Stanley *et al*. ([@b355])                 
  Acetic acid tolerance                                              *S*. *cerevisiae*                                            Nonmodified                                Aarnio *et al*. ([@b1])
  Thermotolerance                                                    *S*. *cerevisiae*                                            UV and EMS-mutagenized                     Balakumar *et al*. ([@b19])
  Copper resistance                                                  *S*. *cerevisiae*                                            Nonmodified                                Adamo *et al*. ([@b3])
  *C*. *humilis*                                                     Nonmodified                                                                                             
  Cobalt resistance                                                  *S*. *cerevisiae*                                            EMS mutagenized                            Cakar *et al*. ([@b53])
  Tolerance to inhibitors in lignocellulosic hydrolysates            *S*. *cerevisiae*                                            Nonmodified                                Almario *et al*. ([@b6])
  Freeze tolerance                                                   *S*. *cerevisiae*                                            UV mutagenized                             Teunissen *et al*. ([@b371])
  Glycerol production                                                *S*. *cerevisiae*                                            Nonmodified                                Kutyna *et al*. ([@b200])
  Wine fermentation properties                                       *S*. *cerevisiae*                                            Metabolic engineered and EMS mutagenized   Cadière *et al*. ([@b50])
  Flux through pentose phosphate pathway                             *S*. *cerevisiae*                                            Metabolic engineered and EMS mutagenized   Cadière *et al*. ([@b50])
  Fermentation under high-gravity conditions                         *S*. *pastorianus*                                           EMS mutagenized                            Huuskonen *et al*. ([@b164])
                                                                     *S*. *pastorianus*                                           UV mutagenized                             Blieck *et al*. ([@b35])
  Ethanol tolerance, growth, and high osmotic stress                 *S*. *pastorianus*                                           EMS mutagenized                            Ekberg *et al*. ([@b105])
  Oxidative, freeze--thawing, high temperature, and ethanol stress   *S*. *cerevisiae*                                            EMS mutagenized                            Cakar *et al*. ([@b52])
  Utilization of glucose, xylose, and arabinose mix                  *S*. *cerevisiae*                                            Metabolic engineered and EMS mutagenized   Wisselink *et al*. ([@b406])
  Anaerobic growth on xylose                                         *S*. *cerevisiae*                                            Metabolic engineered and EMS mutagenized   Sonderegger & Sauer ([@b351])
  Xylose fermentation                                                *S*. *cerevisiae*                                            Metabolic engineered                       Shen *et al*. ([@b342])
  *S*. *cerevisiae*                                                  Metabolic engineered, EMS mutagenized, and genome shuffled   Demeke *et al*. ([@b91])                   

*C*. *humilis*, *Candida humilis*; *S*. *cerevisiae*, *Saccharomyces cerevisiae*; *S*. *pastorianus*, *Saccharomyces pastorianus*; *S*. *uvarum*, *Saccharomyces uvarum*; EMS, ethyl methane sulfonate; UV, ultraviolet.

Directed evolution is most commonly used to fine-tune a specific phenotype that is already present in the starting strain but is not optimal yet. The initial population can be completely isogenic, using a single, often already commercially used, strain as starting point. To increase genetic variability of the starting population, researchers have also used UV- or EMS-mutagenized populations to initiate directed evolution strategies (see also paragraph on 'Mutagenesis' and Table[4](#tbl4){ref-type="table"}). Directed evolution can also be used to further optimize characteristics of (industrial) yeast strains created through other methods, such as metabolic engineering or genome shuffling. A prime example of a phenotype improved in such a way is fermentation of the pentose sugar xylose (Sonderegger & Sauer, [@b351]; Wisselink *et al*., [@b406]; Demeke *et al*., [@b91]). Although this sugar is present in high amounts in the lignocellulosic biomass that is frequently used for second-generation bioethanol production, *S. cerevisiae* is unable to metabolize xylose. Several studies have engineered this novel metabolic capacity into *S. cerevisiae* and subsequently used a directed evolution approach to further optimize xylose fermentation. Starting from a commercially used bioethanol strain, Demeke *et al*. ([@b91]) applied metabolic engineering to introduce the necessary enzymes for xylose utilization, followed by mutagenesis and genome shuffling. Finally, the resulting strains were evolutionarily adapted by serial transfer in spruce hydrolysate containing D-xylose. One of the final clones isolated showed an increased fermentation performance on xylose and was also tolerant to growth inhibitors commonly found in lignocellulosic hydrolysates. Importantly, the evolved phenotype remained stable in the absence of selective pressure.

The advent of novel sequencing technologies has now also made it possible to sequence the complete genomes of evolved strains. Together with expression analysis of evolved clones, this can yield insight into how a specific phenotype is established. It can yield valuable information to guide other methods of strain improvement, such as reverse metabolic engineering.

Selection of phenotypically improved cells and outcrossed hybrids
-----------------------------------------------------------------

A crucial factor determining the success rate of the improvement techniques mentioned above is the selectability of the targeted trait and, in case of hybridization experiments, of the outcrossed hybrids. Whereas some phenotypes, such as stress resistance, allow for a relatively easy high-throughput screening, selecting for so-called difficult phenotypes, such as general fermentation performance or flavor production, is much more labor-intensive and can limit the applicability of the strain improvement technique. Below, different approaches to select improved cells or hybrids from a heterogeneous population are discussed.

### Selection of phenotypically improved cells

In all screens of natural or artificially created yeast diversity, the choice of the selection procedure is vital. Depending on the targeted phenotype, this selection step can be straightforward or extremely difficult and/or labor-intensive. Cells with improved tolerance for a specific stress factor can be readily selected from a pool of millions of different cells by applying this specific stress and selecting the surviving or growing cells. For example, cells with improved thermotolerance are easily isolated by mass growth on high temperatures (Steinmetz *et al*., [@b357]). Apart from selection procedures based on improved stress tolerance, the use of chemical analogs of nutrient sources or intermediary metabolites to select mutants with an altered metabolism is a widely used selection technique. The best-known examples are the isolation of mutants defective in *URA3* or *LYS2* using a selection medium supplemented with 5-fluoroorotic acid (5-FOA) or α-aminoadipic acid (α-AA), respectively (Zaret & Sherman, [@b420]; Boeke *et al*., [@b37]). 5-FOA and α-AA are analogs of intermediary metabolites in the biosynthesis of uracil and lysine, respectively, and each is converted to a toxic compound by *URA3* (in the case of 5-FOA) and *LYS2* (in the case of α-AA). Cells that have acquired a disruptive mutation in *URA3* (or *LYS2*) will not produce and accumulate the toxic compound anymore and can thus grow on the supplemented medium. Mutants containing these so-called counter-selectable 'auxotrophic' markers can then be used in, for example, hybridization experiments (see section on 'Generation of artificial diversity'). Other examples where chemical analogs can be used to select phenotypically improved variants are approaches to select cells lacking catabolite repression. These experiments used fermentation medium supplemented with nonmetabolizable glucose analogs, such as glucosamine (Hockney & Freeman, [@b155]) or 2-deoxyglucose (Jones *et al*., [@b178]). In addition, the growth medium used in these experiments contained maltose (or a different nonpreferred sugar) as the sole assimilable carbon source. Consequently, only cells in which the genes required for utilization of the nonpreferred sugar are not inhibited by the glucose analog are able to multiply. These mutants are of particular interest for the beer industry, where efficient co-fermentation of glucose and maltose, two important carbon sources in beer wort, can significantly shorten the fermentation time.

In other cases, it is difficult to directly select superior variants. However, the close association of certain easy and difficult phenotypes sometimes allows efficient selection for these latter phenotypes. For instance, genome shuffling studies often ultimately aim for improving general fermentation performance. However, because it would be too laborious to test each of the newly generated hybrids individually in small-scale fermentations (therefore making general fermentation performance a 'difficult' phenotype), researchers have found several ways to circumvent this issue. Firstly, it is possible to carry out a prescreening by subjecting the hybrid population to a severe stress by plating the cells on medium that contains for instance high ethanol or acetic acid levels, conditions encountered during fermentation. Next, only fast-growing colonies are tested individually in small-scale fermentations, and only superior hybrids are used for a next round of shuffling (Shi *et al*., [@b343]; Zheng *et al*., [@b426], [@b427], [@b428], [@b429]; Tao *et al*., [@b368]). Other investigators have instead tried to first improve stress tolerance and found that hybrids generated after multiple rounds of genome shuffling and selection also showed increased general fermentation performance (Wei *et al*., [@b403]; Cao *et al*., [@b56], [@b54], [@b55]; Hou, [@b159]; Wang & Hou, [@b396]; Jingping *et al*., [@b176]; Lu *et al*., [@b228]; Wang *et al*., [@b397]). Alternatively, some researchers inoculated their entire hybrid population in a very high-gravity fermentation and harvested cells for a next round of shuffling when the viability of the culture had considerably dropped, thereby enriching for the best adapted hybrids (Hou, [@b160]; Liu *et al*., [@b221]).

Similar to general fermentation performance, screening for cells with an improved flavor production profile can be extremely difficult, because differences in flavor production do not result in a clear and easily selectable fitness advantage for the yeast cell. Therefore, the main bottlenecks of strain improvement strategies for flavor production are the labor-intensive fermentation experiments of each individual hybrid or mutant, followed by measurements of the produced flavor compounds to select the individuals showing an improved flavor profile. To avoid this, several strategies that use chemicals that favor strains with a higher production of flavor (precursors) were developed. For example, an increased production of specific aromatic higher alcohols can be achieved by selecting strains with higher resistance to amino acid precursor analogs, such as 5,5,5-trifluoro-[d]{.smallcaps},[l]{.smallcaps}-leucine, a leucine analog, 2-fluoro-[l]{.smallcaps}-tyrosine, a tyrosine analog, or p-fluoro-[dl]{.smallcaps}-phenylalanine, a phenylalanine analog (Fukuda *et al*., [@b117]). These analogs select for cells with decreased feedback inhibition of amino acid synthesis and increase the production of, respectively, isoamyl alcohol, tyrosol, and β-phenethyl alcohol. Cerulenin, an inhibitor of fatty acid synthesis, is used to select for increased fatty acid synthesis (Ichikawa *et al*., [@b165]; Vicente *et al*., [@b391]; de Souza *et al*., [@b87]), yielding strains with increased ethyl ester production. An increased production of isoamyl acetate (without increasing ethyl acetate production) was achieved by screening for resistance to pregnenolone. This steroid is detoxified by Atf2, an enzyme also responsible for isoamyl acetate, but not ethyl acetate, production (Kitagaki & Kitamoto, [@b191]). These chemicals can therefore be used to select cells with higher production of flavor compounds from a huge heterogeneous pool of cells, thereby facilitating high-throughput selection of this difficult phenotype.

Other techniques exploit the physiological differences (more specifically the tolerance to stress) of actively growing cells and cells in stationary phase. For example, the higher temperature sensitivity of exponentially growing cells compared to cells in stationary phase can be used to enrich for auxotrophic mutants in a heterozygous population (Walton *et al*., [@b395]). In this setup, a mutagenized (and thus heterogeneous) pool of cells in stationary phase, presumably containing some auxotrophic mutant cells, are transferred to fresh fermentation medium, counter-selecting for specific auxotrophies and inducing exponential growth of prototrophic cells. Next, exponentially growing cells are selectively killed by high temperatures, thereby enriching for auxotrophic mutants. Similarly, nystatin (instead of high temperatures) can be applied, because it acts selectively on actively growing cells (Snow, [@b349]; Sanchez *et al*., [@b330]).

### Selection of outcrossed hybrids

In hybridization experiments, the hybridization efficiency is often very low (e.g. in protoplast fusion), or inbreeding is hugely favored (e.g. in interspecific mating experiments), highlighting the importance of a good screening strategy to select for outcrossed hybrids. Four main strategies are designed to isolate outcrossed hybrids. Firstly, both parental strains can be genetically transformed to introduce resistance against different antibiotics, so that outcrossed hybrids can be selected on medium supplemented with both antibiotics. To this end, plasmid-based approaches (Nakazawa *et al*., [@b259]), genomic insertion of resistance markers, and induction of antibiotic resistance using mutagenic agents (Putrament & Baranowska, [@b304]; Putrament *et al*., [@b305]) have been described. However, an important disadvantage of the first two strategies is that the resulting strains are GM strains, limiting their use in the food and beverage industries. Secondly, if each starting strain contains a different auxotrophy, outcrossed hybrids will be prototrophic and can be selected on appropriate selective medium. However, industrial strains are rarely auxotrophic, and screening for spontaneous or induced auxotrophic mutants is necessary (cf. infra). Thirdly, phenotypic complementation is a method in which each starting strain possesses a unique phenotype that can be easily selected by, for instance, cryotolerance or utilization of a specific carbon source, such as melibiose, in which case the hybrids can be selected for the presence of both phenotypes (Sato *et al*., [@b332]). Lastly, each strain can be reversibly stained with a different fluorescent dye, and after hybridization, fluorescence activated cell sorting (FACS) can be used to enrich for dual-stained cells (Bell *et al*., [@b25]). Alternatively, a combination of each of these strategies can be used.

Discussion -- pros and cons of exploiting natural and artificial diversity
--------------------------------------------------------------------------

The existing natural diversity of yeast strains provides a rich, yet underexplored source of strains with industrial potential. Recent advances in next-generation sequencing technologies have allowed scientists to chart the diversity to an unprecedented level of detail. This revealed that the genetic diversity of currently employed industrial strains is relatively limited. Therefore, high-throughput screening of (natural) yeast collections or investigation of the phenotypic potential of indigenous strains might already yield yeasts with superior characteristics compared to the currently used strains. Moreover, additional (artificial) diversity can be generated through different strain improvement techniques like mutagenesis, sexual hybridization, protoplast fusion, and directed evolution. These strategies have successfully enriched the available biodiversity and yielded strains that valuably contributed to many different industrial fermentation processes. Perhaps the greatest promise lies in the combination of carefully selecting the best strains from the immense natural biodiversity, followed by a (combination of) technique(s) to further improve these natural yeasts in order to generate superior variants for industrial use.

In contrast to the genetic modification approaches described in the next section, one of the advantages of the approaches described above is that the resulting superior yeasts are mostly considered to be non-GMO, and food and beverages produced with these yeasts do not suffer from any problems with specific legislation and/or consumer acceptance. Moreover, they do not require an *a priori* knowledge of the genetic circuitry underlying the phenotype under study. In this way, complex polygenic phenotypes, such as ethanol tolerance, can be improved, without knowing exactly which genes need to be targeted. This allows scientists to use less well-described, nonconventional yeasts in improvement experiments. For example, efficient mutagenesis experiments targeting the basidiomycetous yeast *P. rhodozyma* have been performed for many decades (Brehm-Stecher & Johnson, [@b43]), while only very rudimentary genetic manipulation techniques are available for this organism (Lin *et al*., [@b214]). Additionally, detailed analysis of improved strains (whole-genome sequencing, expression analysis,...) can yield valuable insights into how a specific trait is established. This in turn can point to possible targets for genetic or metabolic engineering and can thus guide other methods of strain improvement.

On the other hand, these 'non-GMO' techniques also have important limitations. First and foremost, they only allow changing yeasts within the limitations of what is achievable through natural diversity, mutation, and crossing. Secondly, it is often difficult to select the few cells that show improved properties from the large and heterogeneous pool of cells. This prevents some industrially desired phenotypes, such as increased production of specific flavor compounds, for which a clear fitness advantage has not been discovered (yet), from being efficiently improved through these approaches. In these cases, selection has to be carried out on individual clones (e.g. in separate fermentation experiments), thereby severely limiting the pool of variants from which improved strains can be selected. In these cases, the best strategy to obtain improved variants is often the use of directed mating, rare mating, or protoplast fusion, where (in contrast to, e.g., mass mating or genome shuffling) parental strains can be thoroughly screened prior to the hybridization event. Thirdly, selection is often limited to the specific phenotype targeted, while other phenotypes are not under selection and may therefore deteriorate during the experiment. This can result in so-called crippled strains: strains performing only well for the targeted phenotype, but performing worse than the parental strain for other (industrially) important phenotypes that were not selected for. To circumvent this issue as much as possible, investigators have tried to evolve (in case of experimental evolution) or select (in case of the other approaches) strains or mutants under conditions very similar to the conditions in which the improved strain will be used in industry. However, practical limitations often prevent mimicking a full-scale industrial setting. Fourth, the complex ploidy of feral and industrial strains (which are often polyploid or even aneuploid) and their distinctive sexual life cycle (which is often characterized by poor sporulation efficiency, low spore viability, and/or homothallism) can severely hamper the success of improvement strategies such as sexual hybridization. Additionally, because of the lack of a sexual life cycle (or if it is not yet discovered), sexual hybridization experiments of several nonconventional yeasts, such as *Candida stellata* (an indigenous wine yeast with interesting oenological properties, cf. infra), are not possible.

Nonetheless, several of these disadvantages can be circumvented by carefully considering the genetic characteristics of the target strain(s) when one selects an improvement strategy, or by combining different techniques. For example, induction of auxotrophies by mutagenesis in industrial strains unable to sporulate (and thus unfit for use in sexual hybridization experiments) can provide mutants with appropriate selection markers for rare mating or protoplast fusion experiments. Alternatively, recombinant DNA technologies can be used, an approach that allows a more targeted strain improvement, which enables researchers to cross the borders of what is present in nature or achievable by mutations or hybridization. This approach will be further discussed in the next section.

Genetic modification
====================

Introduction
------------

The best documented approach of yeast improvement is genetic modification. Genetic modification comprises the controlled and precise modification of an organism\'s genome using recombinant DNA and other molecular techniques, in order to alter a trait of interest. Initial applications of genetic modification consisted of producing human proteins in bacteria and yeast for therapeutic treatments (e.g. Itakura *et al*., [@b169]). By modifying existing biochemical pathways, or even introducing complete heterologous pathways, a huge array of genotypic and phenotypic variability can be generated using recombinant DNA technology. Although this technique is already widely accepted in the pharmaceutical industry, the implementation of GMOs in the food or biofuel industry is still heavily debated.

Strain improvement by genetic modification differs from the non-GMO approaches described above in two important characteristics. Firstly, the DNA of the organism is changed in a specific, predetermined manner, without changing other parts of the genome. This implies that, in theory, one or several phenotypes can be changed, without negatively affecting other important characteristics. This reduces the chance of creating 'crippled' strains (cf. supra). Second, the technique is not limited to naturally occurring or randomly induced mutations. Modern technologies enable changing the DNA code in almost any possible way -- including the transfer of DNA between different species, genera, or kingdoms, and the construction of completely artificial, man-made DNA fragments or even complete chromosomes and genomes (Gibson *et al*., [@b125]; Dymond *et al*., [@b104]). On the other hand, genetic modification also has several limitations compared to non-GMO techniques. Most importantly, genetic modification requires insight into the genetic alterations needed to obtain a desired phenotype. However, some of the newest applications of genetic modification circumvent this problem by, for example, applying 'inverse metabolic engineering' or by combining high-throughput and 'semi-random' genetic modification with selection techniques described above (e.g. 'global transcription machinery engineering'). A second limitation is that genetic modification often involves optimization of specific cloning vectors and transformation protocols and tools for each organism.

Here, we summarize traditional as well as more recent and future approaches for genetically modifying industrial yeasts and discuss several recent industrially relevant outcomes. Although interesting, a historical overview and a discussion of the currently applied shuttle vectors and transformation protocols are only briefly mentioned, but are described extensively elsewhere (e.g. by Struhl, [@b363]; Gietz & Woods, [@b126]; Da Silva & Srikrishnan, [@b82]). The first part of this section will focus on *Saccharomyces* yeasts, while the genetic improvement of a few other, nonconventional yeasts with a well-established role in the fermentation industry is discussed separately.

Principles of genetic modification
----------------------------------

### Recombinant DNA technology

Whereas model bacteria like *Escherichia coli* are relatively easy to manipulate genetically because of their natural propensity to take up and incorporate foreign extracellular DNA, the uptake of foreign DNA into yeast is less efficient, and it was not until the seminal work by Hinnen, Hicks, and Fink in 1978 that yeast was genetically transformed efficiently (Hinnen *et al*., [@b153]). Since then, multiple different techniques and strategies have been developed to introduce recombinant DNA in yeast cells (reviewed by Gietz & Woods, [@b126]), and many different vectors (usually shuttle plasmids) and transformation protocols were designed to efficiently introduce DNA fragments.

There are two major ways to efficiently express foreign DNA in yeasts: using plasmids or fixed integration in the host\'s genome (or a combination of both). Several types of plasmid vectors exist, which allow variation of the copy number of the introduced DNA fragment (e.g. 10--40 copies per cell for 'YEp' vectors and 1--2 copies per cell for 'YCp' vectors; Clarke & Carbon, [@b70]; Christianson *et al*., [@b67]; Romanos *et al*., [@b315]). To ensure stability over multiple generations, these low-copy number 'YCp' vectors carry an origin of replication and a centromere sequence which allows for a high segregational stability of the plasmid under selective conditions. On the other hand, multicopy plasmids have limited segregational stability, which can lead to copy number variation between cells of the same population and thus also cell-to-cell expression heterogeneity.

Engineering of a yeast strain (e.g. for the production of a specific compound) often requires the introduction of multiple heterologous genes or genetic modifications. However, stably maintaining multiple plasmids in one cell, each with a different gene construct, can be difficult (Futcher & Carbon, [@b119]). Bidirectional promoter plasmid series as well as yeast artificial chromosomes exist for these purposes (Murray & Szostak, [@b256]; Miller *et al*., [@b246]; Li *et al*., [@b209]). However, the method of choice for introducing multiple genes is usually integration into the yeast genome. Issues with segregational stability and copy number control when plasmids are used for the introduction of heterologous genes, as well as the need for specific selective conditions during cell propagation to ensure plasmid maintenance and stability, make that a genetically stable engineered strain is usually created by integrating DNA into the yeast genome by homologous recombination. Vector- or PCR-based generated DNA fragments are generally used for insertion. Homologous recombination is highly efficient in *S. cerevisiae*: small flanking regions of homology (30--45 bp) are sufficient for targeted integration into the yeast genome (Manivasakam *et al*., [@b237]). Locations in the yeast genome that are often used for the integration of heterologous DNA fragments include rRNA genes (Lopes *et al*., [@b225]) and delta sequences (Sakai *et al*., [@b327]; Lee & Da Silva, [@b205]). When multiple genes need to be integrated, a dispersed nature of integration sites causes the inserted DNA fragments to be more stably maintained than when tandemly inserted (Da Silva & Srikrishnan, [@b82]).

As mentioned above, there are also several different transformation protocols described. While the initial transformation protocol (Hinnen *et al*., [@b153]) entailed the spheroplasting of yeast cells prior to transformation, protocols using intact cells are considered the golden standard today. The use of intact cells in transformation protocols was already mentioned in 1981. It was fine-tuned in a decisive paper by Ito *et al*. ([@b501]) describing how alkali cations (such as Li^+^) in combination with polyethylene glycol (PEG) increased the efficiency of plasmid DNA uptake. In the next decades, small changes (including the addition of single-stranded carrier DNA or RNA) were made to the protocol, ultimately leading to the transformation method of choice for most yeast scientists today (Gietz & Woods, [@b126]). Alternative methods using electroporation or glass beads successfully increased the speed of the protocol, but are often less preferred due to higher equipment costs (electroporation) or a lower yield of transformants (glass beads; Gietz & Woods, [@b126]). For the introduction of mitochondrial genes, the most effective current protocol includes the use of biolistic methods, where yeast cells are bombarded with 0.5-μm gold or tungsten projectiles coated with DNA using compressed helium.

### From genetic to metabolic engineering

In the 1980s and especially the 1990s, many research groups adopted the principles of recombinant DNA technology and started developing new, improved yeast strains for industrial processes using this technology (Dequin, [@b92]). Initially, these experiments were focusing on single genes and enzymes, aiming to manipulate genes directly involved in creating the product of interest (Tyo, [@b378]). This approach is mostly referred to as 'genetic engineering', although this term is often used in a broader context. In 1991, two seminal papers (Bailey, [@b16]; Stephanopoulos & Vallino, [@b360]) introduced a novel systematic approach of genetic modification where multiple genes were targeted, termed 'metabolic engineering'. This technique uses directed modification of metabolic pathways and/or their regulation to optimize or establish the synthesis of various products (Ostergaard *et al*., [@b276]; Stephanopoulos, [@b359]). The main targets for modulation are enzymes, transporters, and regulatory proteins (Woolston *et al*., [@b408]). The opportunities of metabolic (and genetic) engineering include adjusting or fine-tuning the (1) gene expression level, (2) gene expression regulation, (3) *in vivo* protein/enzyme activity, and (4) protein subcellular location (Nevoigt, [@b261]). Key in this approach is the availability of detailed genetic information about the relevant pathways, enzymes, and their regulation. Using this information, a model on how these protein activities can be optimized to achieve the desired metabolic flux or phenotypic trait is built, and targeted genetic modifications using recombinant DNA technology are performed.

When aiming to optimize a specific trait by metabolic engineering, there are several important factors to keep in mind. First, high expression levels of heterologous genes are not always desirable because it can impose a significant metabolic burden on the cell (e.g. through the depletion of cofactors). Moreover, high enzyme levels do not necessarily correspond to the optimal level needed for production of a specific compound (see, for example, the article by Jin *et al*., [@b175]). Therefore, optimization of both the promoter and terminator region of the targeted gene(s) is crucial. Both constitutive and inducible promoters of varying strength are available for metabolic engineering of yeast, and several expression-enhancing terminators for *S. cerevisiae* were identified (Curran *et al*., [@b80]). Additionally, several methods to develop synthetic promoter libraries with promoter variants spanning a wide range of 'activities' have been developed (Jensen & Hammer, [@b173]; Jeppsson *et al*., [@b174]; Alper *et al*., [@b8]). This allows researchers to perform screenings with these libraries in order to fine-tune gene expression for their specific application. For example, error-prone PCR (see 'Novel techniques') was applied to the strong constitutive *TEF1* promoter of *S. cerevisiae*, generating promoters with a strength ranging from 8% to 120% of the native *TEF1* promoter (Alper *et al*., [@b8]; Nevoigt *et al*., [@b262]). A similar approach was used to generate a promoter library based on the constitutive *GAP* promoter for *Komagataella* (*Pichia*) *pastoris* (Qin *et al*., [@b306]).

Secondly, expression levels of multiple genes of a particular pathway often need to be optimized to balance metabolic flux within this pathway. For example, multiple gene promoter shuffling allows to find the optimal levels of expression of multiple genes at a time (Lu & Jeffries, [@b227]). In this approach, promoters of varying strength are fused to the genes of interest, these constructs are joined via ligation, and subsequently, a screen for the phenotype of interest is performed. A similar method, termed COMPACTER (customized optimization of metabolic pathways by combinatorial transcriptional engineering), was used for fine-tuning the expression of heterologous genes involved in xylose and cellobiose metabolization pathways introduced in *S. cerevisiae* (Du *et al*., [@b95]). This latter study also demonstrated that the optimal expression level strongly depends on the genetic background.

Thirdly, apart from regulation at the level of transcription, protein levels also depend on translational efficiency, and this in turn is highly influenced by codon usage. Codon optimization of heterologous genes, by changing codons to codons of highly expressed genes, such as glycolytic genes in the case of *S. cerevisiae*, can significantly increase protein levels (Wiedemann & Boles, [@b405]; Brat *et al*., [@b42]). Interestingly, even expression of endogenous genes can be increased through codon optimization (Brat *et al*., [@b42]).

### Inverse metabolic engineering

As already indicated above, a crucial factor determining the applicability of metabolic engineering is the detailed knowledge and understanding of genetics underlying a certain trait or pathway. The lack of knowledge often impedes the success of metabolic engineering approaches, even for an intensively characterized model organism like *S. cerevisiae*. To circumvent this drawback, a novel approach of metabolic engineering called 'inverse metabolic engineering' was described (Bailey *et al*., [@b17]), conceptually identical to the more generally used term 'reverse engineering' (Oud *et al*., [@b279]). Roughly put, the rationale of inverse metabolic engineering is very similar to classical biochemical genetics, yet including newer techniques.

In this approach, the initial step consists of unraveling the genetics underlying an interesting, but genetically cryptic phenotype observed in a certain strain or condition. Next, this information is used to optimize a production strain. In practice, the first step can be achieved by screening a heterogeneous yeast collection for the phenotype of interest. The diversity in the collection can both be natural (e.g. a large collection of different industrial strains) or artificially created (e.g. by mutagenesis or genome shuffling). Next, the genotype--phenotype relationship of this trait must be unraveled. This can be accomplished by genetic mapping or genetic association analysis (reviewed by, e.g., Liti & Louis, [@b218]) or by using -omics technologies to analyze differences in gene, mRNA, protein, or metabolite abundance in different conditions or in different strains and link it to the observed phenotype. Lastly, this information is used to genetically modify a production strain.

Inverse metabolic engineering has already yielded various industrial strains (cf. infra; Bro *et al*., [@b44]; Blieck *et al*., [@b35]; Rossouw *et al*., [@b317]; Yoshida *et al*., [@b411]; Perez-Torrado *et al*., [@b292]; Duong *et al*., [@b101]). A clear example of how inverse metabolic engineering can be applied to target complex phenotypes is a study by Rossouw *et al*. ([@b317]). By studying the transcriptome and exo-metabolome of several wine yeasts during fermentation conditions, a link between expression of certain genes (*BAT1*, *AAD10*, *AAD14,* and *ACS1*) and production of aroma compounds was identified and subsequently confirmed by overexpressing these genes in a commercial wine yeast (Rossouw *et al*., [@b317]). Similarly, Yoshida *et al*. ([@b411]) identified genes involved in sulfite production of baker\'s yeast by combined analysis of the transcriptome and endo-metabolome, and successfully applied this knowledge to engineer a lager\'s yeast strain that produced high sulfite, but not excessive sulfide concentrations (Yoshida *et al*., [@b411]).

### Synthetic biology

A relatively new and incredibly powerful strategy for creating novel industrial yeast strains relies on synthetic biology. Broadly, the goal of synthetic biology is the design and construction of new biological parts, devices, and systems \[ranging from (parts of) single genes to completely new organisms\], or re-designing existing, natural biological systems for useful purposes. Using individual genetic elements (sometimes referred to as 'biobricks'), synthetic biology assembles more complex genetic systems such as metabolic pathways (Stephanopoulos, [@b359]). The term 'synthetic biology' comprises two different approaches: The first is the use of man-made molecules to mimic natural molecules with the goal of creating artificial life. The second is the use of natural molecules to assemble a system that acts unnaturally.

Although *S. cerevisiae* has many desirable characteristics for use in synthetic biology, the preferred model organism of synthetic biologists is *E. coli* (see, e.g., the articles by Fung *et al.,* [@b118]; Levskaya *et al*., [@b208]). However, the pioneering work of the J. Craig Venture institute has shown that yeasts have the ability to assemble and maintain entire bacterial genomes, indicating that large synthetic networks could be constructed and implemented in the yeast\'s DNA arsenal (Gibson *et al*., [@b125]). Moreover, the Synthetic Yeast 2.0 (Sc2.0) project, a project seeking to reconstruct and redesign the full *S. cerevisiae* yeast genome, is progressing swiftly. This recently yielded the publication of the first partially synthetic eukaryotic chromosomes, synIXR, and semi-synVIL (Dymond *et al*., [@b104]).

Production of certain valuable compounds through complex pathways was already achieved in *S. cerevisiae*, for example the antimalarial drug precursor artemisinic acid (Ro *et al*., [@b311]). In this study, a mevalonate pathway, amorphadiene synthase (*ADS*), and a novel cytochrome P450 monooxygenase (*CYP71AV1*) from *Artemisia annua* were introduced and expressed in *S. cerevisiae*, yielding titers up to 100 mg L^−1^ of artemisinic acid when cultured in a simple growth medium.

Theoretically, the possibilities of synthetic biology are endless. However, it is unlikely that creating fully functional and optimal yeasts for industrial processes from scratch will occur in the very near future. Although it is often stated that the availability of biobricks will be the major bottleneck in advances in synthetic biology, a more fundamental challenge will likely be to completely map and design a functional cell and optimize it to the level of robust performance required for commercial operation (Stephanopoulos, [@b359]). That is why, so far, the majority of studies applying synthetic biology are still leaning more toward basic biology rather than applied research (Serrano, [@b340]; Dymond *et al*., [@b104]; Voordeckers *et al*., [@b393]).

GM *Saccharomyces* yeasts for the production of fermented foods
---------------------------------------------------------------

The use of GM yeasts in food fermentation processes is still controversial and heavily debated. Nonetheless, numerous research groups and companies are using genetic modification to alter industrial yeast properties. In this section, an overview of the most notable progress in industrial yeasts engineered with recombinant DNA technologies for the production of foods and beverages is given. Phenotypes that are often targeted in these strains can be broadly categorized into four different groups: (1) propagation, fermentation and storage efficiency, (2) sensorial quality of the end product, (3) health-related quality of the end product, and (4) microbial stability. It is important to note that some phenotypes show overlap between these different areas; for example, the production of a high concentration of glycerol can be both of sensorial importance and a health-driven approach to lower the ethanol content of beverages. Below, some examples of previous research studies in these areas are discussed; an extensive overview is given in Supporting Information, [Table S2](#sd2){ref-type="supplementary-material"}.

### Propagation, fermentation, and storage efficiency

Environmental conditions during fermentation or propagation are often harsh for yeast cells, which are faced with, and must quickly respond to, fluctuations in dissolved oxygen concentration, pH, osmolarity, ethanol concentration, nutrient supply, and temperature (reviewed by Gibson *et al*., [@b124]). Hence, the development of more robust strains that are still capable of producing a high-quality end product is a prime focus in biotechnology (Kim *et al*., [@b187]; Perez-Torrado *et al*., [@b291], [@b292]; Panadero *et al*., [@b282]; Kaino *et al*., [@b180]; Gomez-Pastor *et al*., [@b132]). For example, using an inverse metabolic engineering approach, Perez-Torrado *et al*. ([@b292]) identified two genes, *CAF19* and *ORC2*, important for osmotolerance. Overexpression of these genes exerted a positive impact on the leavening activity of baker\'s yeast. In a different study, Kaino *et al*. ([@b180]) improved the freeze tolerance of baker\'s yeast by increasing the intracellular proline accumulation. Disrupting *PUT1* (encoding a proline oxidase) and replacing the wild-type *PRO1* (encoding a γ-glutamyl kinase) by a modified allele less sensitive to proline feedback inhibition significantly increased the freeze tolerance of commercial baker\'s yeast without influencing the fermentation ability.

The composition of the medium used for fermentation or propagation can be another cause of suboptimal yeast performance. Molasses for example, a cheap medium classically used for yeast propagation, is generally suboptimal for the generation of high amounts of biomass of Crabtree-positive yeasts, like *S. cerevisiae*, because these yeasts prefer a fermentative lifestyle when glucose is present, which leads to inefficient use of the substrate. Regulation of the central carbon flux to improve biomass yield has been a major target in strain improvement. For example, overexpression of *HAP4*, a transcriptional regulator of respiration-related genes, led to a redirection from fermentation to respiration flux and a concomitant increase in biomass production (Duenas-Sanchez *et al*., [@b96]). In many cases, multiple nonpreferred carbon sources, like maltose, maltotriose, galactose, fructose, and melibiose, or nonpreferred nitrogen sources, like proline and arginine, are present in the propagation or fermentation medium used in industrial applications. Efficient utilization of these nutrients can be achieved by neutralizing catabolite repression or modifying various regulators, enzymes, or transporters (Klein *et al*., [@b193]; Salmon & Barre, [@b329]; Higgins *et al*., [@b152]; Guillaume *et al*., [@b136]). For example, in the wine industry, stuck fermentations are sometimes caused by the inability of yeast to metabolize all fructose present in the wine must. By introducing a mutated *HXT3* gene (coding for a hexose transporter), wine yeasts can become able to completely ferment grape must sugars (Guillaume *et al*., [@b136]). Similarly, introduction of a modified high-affinity specific proline permease gene (*PUT4*) in a lager yeast resulted in strains with an improved proline assimilation profile during lager fermentations (Omura *et al*., [@b275]). Furthermore, a beer yeast able to utilize dextrins, leading to the production of highly attenuated beers, was the first GM strain that was approved by the British government for commercial use (Hammond, [@b143]; cf. supra). However, due to the negative perception of GMOs by consumers (often fueled by specific organizations), this strain has never attained commercial success.

Lastly, yeast physiology can also be altered to facilitate downstream handling of the fermentation product. For example, flocculation facilitates the removal of the biomass and thus clarification of, for example, beer or sparkling wine. Related to this phenotype is 'flotation', which is the ability of yeast cells to trap CO~2~ bubbles in a fermenting liquid and form a film or vellum at the top of fermentation vessels, for example in traditional ales or flor sherry (Pretorius, [@b301]; Verstrepen *et al*., [@b385], [@b388]). Both traits are linked to expression of *FLO* genes, and modifying these genes (Ishida-Fujii *et al*., [@b168]) or coupling their expression to a suitable promoter (Verstrepen *et al*., [@b387]) can enable appropriate timing and intensity of yeast aggregation.

### Sensorial quality

The distinctive aroma of wine, beer, sake, spirits, bread, and all other fermented foodstuffs is highly affected by many yeast-associated compounds, including esters, higher alcohols, ketones, phenolic compounds, sulfuric compounds, and terpenes. Consequently, increased or decreased production of these aroma-active compounds is a main focus of several studies. In addition, yeast-induced flavor stability has also received some attention, for example by increasing the production of antioxidants such as glutathione and sulfite, which delays staling of fermented beverages.

Although volatile esters and higher alcohols are only present in trace amounts in fermented beverages such as beer and wine, they are extremely important for the flavor profile (Verstrepen *et al*., [@b388]). As already mentioned above, strains with improved flavor production cannot be easily selected from large pools of variants, and therefore, many improvement strategies targeting this phenotype, such as genome shuffling or directed evolution, require testing of individual clones. As a result, much research has focused on the use of genetic modification to produce strains with superior ester and higher alcohol profiles. The regulatory mechanisms and factors influencing the production of these secondary metabolites are still not completely understood, but fine-tuning expression of specific genes, like *ATF1*, *BAT1*, and *EHT1*, has proven to be a fruitful strategy for strain improvement (Hirata *et al*., [@b154]; Lilly *et al*., [@b212], [@b213]; Verstrepen *et al*., [@b388]; Blieck *et al*., [@b35]; Rossouw *et al*., [@b317]; Zhang *et al*., [@b422]).

Similarly, reduction of unwanted off-flavors, like diacetyl and dimethyl sulfide (DMS) in beer or H~2~S in wine or beer, is also an important target in strain improvement. Interestingly, some aroma-active compounds, like 4-vinyl guaiacol, a phenolic compound, are considered to be unwanted off-flavors in some fermented beverages (e.g. in most ale beers or sake), while in limited concentrations they are perceived positively in certain wines. As a result, some studies focus on eliminating phenolic compounds from yeast metabolism, while others try to promote or balance their production, for example by introducing heterologous genes encoding a phenolic acid decarboxylase from *Bacillus subtilis* and the p-coumaric acid decarboxylase from *Lactobacillus plantarum*. This approach leads to a significant increase in the formation of volatile phenols (Smit *et al*., [@b348]).

The potential of yeast strains to produce or utilize certain organic acids, and therefore influence the (volatile) acidity or rheology of the food, is another major focus for strain improvement. Obtaining a balanced acidity profile by fine-tuning production of citric, succinic, malic, lactic, and acetic acid, or allowing yeasts to perform malolactic wine fermentations, have all been studied in detail. ML01, a strain engineered for this latter purpose, has been approved for commercial wine production in a number of countries, including the USA, Canada, and Moldova (Chambers & Pretorius, [@b62]). This strain carries two chromosomally integrated heterologous genes -- the *Schizosaccharomyces pombe* malate transporter gene (*mae1*) and the *Oenococcus oeni* malolactic enzyme gene (*mleA*) -- regulated by the *S. cerevisiae PGK1* promoter and terminator, and is able to simultaneously metabolize malic acid and perform an alcoholic fermentation (Husnik *et al*., [@b163]).

### Health-related quality

There is an increasing interest to use genetic modification to improve the nutritional and/or health-promoting qualities of foods. For example, decreasing the concentration of ethyl carbamate, a suspected carcinogen that occurs in most fermented foods and beverages, is an important goal. In aging wines or sake, the concentration of ethyl carbamate, which is mainly formed by a spontaneous reaction of ethanol with urea, can be relatively high (Pretorius & Bauer, [@b302]; Dahabieh *et al*., [@b83]). By adjusting the urea catabolism of the yeast strain, ethyl carbamate concentrations can be significantly lowered (Kitamoto *et al*., [@b192]; Coulon *et al*., [@b78]; Dahabieh *et al*., [@b83]). The most successful resulting strain so far, called 522^EC−^, was approved for commercial use (Chambers & Pretorius, [@b62]). In 522^EC−^, *DUR1,2* is constitutively expressed, causing the degradation of urea and thus minimizing the amount of urea released in the medium (Coulon *et al*., [@b78]).

Secondly, the production of health-promoting substances such as antioxidants and/or compounds that are believed to protect against DNA damage also becomes more and more important (Becker *et al*., [@b24]; Wang *et al*., [@b399]). Because *S. cerevisiae* does not produce most of these compounds naturally, heterologous expression of genes from other species is required. For instance, carotenoids, tetraterpenoids consisting of 40 carbon atoms, are of interest because they possess antioxidant activities, but can also be applied as coloring agents (see the review by Victor & Bhatia, [@b392]). Early studies reported β-carotene and lycopene production, although at low levels, in *S. cerevisiae* by overexpression of the bacterial genes involved in biosynthesis of carotenoids from episomal vectors (Yamano *et al*., [@b409]). Higher levels \[5.9 mg g^−1^ (dry weight)\] of β-carotene were achieved by chromosomal integration and overexpression of genes from the red yeast *X. dendrorhous* (Verwaal *et al*., [@b390]).

Terpenes are another class of molecules that, in addition to their contribution to the aroma of fermented foodstuffs and use as dyes, are of interest for nutritional and medical purposes. Various metabolic engineering strategies in *S. cerevisiae* have been adopted to express terpenes (described, for instance, by Liu *et al*., [@b222]). For example, Rico *et al*. ([@b310]) engineered a wine yeast to produce linalool by the heterologous expression of the linalool synthase gene from *Clarkia breweri*. In addition, the titer could be doubled by overexpression of the native enzyme 3-hydroxy-3-methylglutaryl coenzyme A reductase, which formed the rate-limiting step in the endogenous mevalonate pathway.

Resveratrol is a compound that, apart from its antifungal characteristics, has been proposed to reduce the risk of cancer and coronary heart disease (Jang *et al*., [@b170]; Becker *et al*., [@b24]). Introducing a low-affinity, high-capacity *E. coli* arabinose transporter gene (*araE*) or introducing a mutated, codon-optimized tyrosine ammonia lyase gene from *Rhodobacter sphaeroides* into yeast significantly enhanced resveratrol production (Wang *et al*., [@b399]). In addition, Sydor *et al*. ([@b364]) expressed the *Arabidopsis thaliana* gene coding for 4-coumaroyl-coenzyme A ligase and the *Vitis vinifera* gene for stilbene synthase in various strains and found that, together with using rich medium, an industrial sugarcane-fermenting yeast strain reached a resveratrol titer of 391 mg L^−1^.

Thirdly, due to the increasing demand for healthier foodstuffs, the reduction of ethanol and carbohydrates in alcoholic beverages, especially beer and wine, is of considerable commercial interest (Pretorius, [@b301]; Kutyna *et al*., [@b199]; Saerens *et al*., [@b325]). Reducing the level of (nonfermentable) dextrins in beer wort yields beers with less carbohydrates and thus a lower caloric content. The production of such 'light' or 'diet' beers can be achieved by adding exogenous enzymes (which is inefficient and expensive) or by developing yeast strains that can produce and secrete starch-decomposing enzymes such as α-amylase (Perry & Meaden, [@b294]; Steyn & Pretorius, [@b361]; Hammond, [@b143]; Randezgil *et al*., [@b307]; Marin *et al*., [@b239]). A dextrin-assimilating brewer\'s yeast, equipped with the *S. cerevisiae* (var. *diastaticus*) gene *STA2,* encoding an extracellular glucoamylase, is one of the few genetically engineered strains to receive official approval for commercial use from the British Government (Hammond, [@b143]; Dequin, [@b92]). However, as already mentioned above, negative perception of this GMO by consumers hampered its commercial success.

Next to low-calorie beverages, there is an increasing demand from both consumers and producers for fermented beverages with reduced alcohol content, but without the loss of product quality (Kutyna *et al*., [@b199]). It is argued that excessive alcohol levels in wines can compromise wine quality and cause health issues, while the costs to the consumer in countries where taxes are calculated based on ethanol content increase. Approaches implementing additional processing steps, like postfermentation removal of alcohol, or modified fermentation parameters, yielded only beverages with inferior quality and usually implicated extra processing costs. Numerous strategies, mainly based on targeting genes involved in glycerol production or regulating the redox balance, have been described to alter yeast carbon flux in order to reduce ethanol production. Due to the drastic nature of this metabolic reorganization, a balanced and well-considered combination of different strategies, for example as described in Cordier *et al*. ([@b77]), will probably yield the most useful outcome. This strategy employs the combined effect of genes involved in glycerol production and transport (*FPS1* and *GPD1*), conversion of DHAP to GAP in the glycolysis pathway (*TPI*), and the conversion of acetaldehyde to ethanol and acetic acid (*ADH1* and *ALD3*).

Because of the high consumer concerns about safety and other health-related properties of foodstuffs, and the solutions GM yeasts can provide for these potential problems, it is plausible that the use of GMOs in this field might be the key to a more rational and balanced consumer attitude to GMOs in the field of foods and beverages and pave the way for broader applications.

### Microbial stability

The quality of fermentation products largely depends on the microbial actors in the fermenter. Contamination during the fermentation usually has dramatic effects on the fermentation efficiency and/or sensorial quality of the end product. To prevent contamination by other microorganisms during fermentation, yeast strains with antimicrobial properties have been developed, either by hybridization or by genetic engineering. The most commonly applied strategy is to equip the yeast strain with a killer phenotype, such as K1 (Boone *et al*., [@b39]), which makes it capable of producing antifungal toxins, to which the strain itself is immune (Schmitt & Breinig, [@b337]). Sporadically, there are reports of strains with other engineered antifungal (Carstens *et al*., [@b59]) or antibacterial properties (Schoeman *et al*., [@b338]).

GM *Saccharomyces* yeasts for the production of biofuels
--------------------------------------------------------

The modern biofuel industry confronts industrial microorganisms with specific challenges that differ from those encountered in many food fermentations. Whereas *S. cerevisiae* has been used for thousands of years in a wide range of food-related fermentations, the substrates used for these traditional fermentations differ significantly from the complex substrates and harsh conditions in second-generation biofuel production processes. Moreover, *S. cerevisiae* is now also used to produce a range of different biofuels such as butanol, which is not a natural fermentation product of the common brewer\'s yeast. Microorganisms that naturally utilize these complex substrates or produce these compounds, such as *Sc. stipitis* for xylose metabolism and *Clostridium acetobutylicum* for butanol production, come with disadvantages. These include a lack of knowledge on genetics and physiology, limited stress and/or alcohol tolerance, and the lack of a molecular toolbox to modify the organism\'s characteristics (Alper & Stephanopoulos, [@b7]). Metabolic and genetic engineering strategies have been and still are being developed to modify the classical fermentation workhorse *S. cerevisiae* in order to tackle these new challenges. A detailed overview of all metabolic engineering strategies for biofuel production falls outside the scope of this review, but in this section we briefly discuss the most important contributions of genetic modification to various characteristics relevant to the modern biofuel industry.

### Substrate range

*Saccharomyces cerevisiae* efficiently ferments a range of hexose sugars (including the disaccharide maltose and the trisaccharide maltotriose) into ethanol, and it is therefore the organism of choice in first-generation bioethanol production. However, it cannot consume pentose sugars like xylose, the most abundant pentose in lignocellulose and the chief substrate for second-generation biofuels. Researchers have explored two main strategies to introduce and express genes from various pentose-utilizing microorganisms into *S. cerevisiae*, in order to make it capable of utilizing these nonpreferred sugars \[see reviews by Van Vleet & Jeffries ([@b382]) and Young *et al*. ([@b413])\]. In the first strategy, expression of heterologous genes, typically from *Sc. stipitis,* coding for xylose reductase (XR) and xylitol dehydrogenase (XDH) allowed xylose fermentation (Tantirungkij *et al*., [@b367]). However, the resulting strains were suboptimal because XR and XDH require different co-factors (NADPH vs. NAD^+^), causing a cellular redox imbalance that in turn leads to the secretion of xylitol and a low ethanol yield. Protein engineering, experimental evolution, and fine-tuning of gene expression have been used to further improve these strains. While some strains show significant improvements, yields are often still too low for successful commercial applications (reviewed by Matsushika *et al*., [@b243]).

A second strategy to obtain xylose-fermenting *S. cerevisiae* strains exploits a metabolic route mainly present in prokaryotes. A heterologous gene coding for xylose isomerase is expressed in *S. cerevisiae*, allowing a one-step conversion from xylose to D-xylulose, which can be readily utilized by *S. cerevisiae*, albeit at low rate (Kuyper *et al*., [@b201]; van Maris *et al*., [@b502]; Madhavan *et al*., [@b235]). This strategy circumvented the redox imbalance problem of the first strategy, but xylose consumption rates turned out to be lower (Madhavan *et al*., [@b235]). To further improve these strains, additional metabolic and evolutionary engineering strategies were used, again with varying levels of success (Matsushika *et al*., [@b243]).

In addition to targeted metabolic engineering strategies to further optimize xylose fermentation, other techniques have also been used. Interestingly, these techniques combine aspects of non-GMO techniques (where the best-performing organisms are selected from a large pool of natural or man-made variants) with genetic modification. For instance, Liu *et al*. ([@b220]) adopted global transcription machinery engineering (gTME; see section on 'Novel techniques' below) to select mutants on medium with xylose as the only carbon source and were able to identify an isolate with improved xylose fermentation. Ni *et al*. ([@b263]) used an insertional transposon mutagenesis screen (see section 'Novel techniques') to identify gene deletions that could enhance growth on xylose in an engineered strain.

Although these strategies successfully expanded the substrate range of *S. cerevisiae*, the resulting strains were rarely directly applicable in an industrial setting because the yields and/or fermentation efficiency and/or the stress resistance of the resulting strains were too low. In addition to optimized xylose metabolism, efficient biofuel strains must also be capable of dealing with general (osmotic pressure, ethanol toxicity) and specific (inhibitors formed during lignocellulose pretreatment) stress factors during the industrial fermentation. Equipping an established industrial biofuel strain, instead of a laboratory strain, with xylose metabolism therefore seems a promising strategy (Demeke *et al*., [@b91]).

### Ethanol yield

One of the key parameters for industrial application of a biofuel production strain is yield. Therefore, multiple genetic modification approaches aim at improved substrate utilization and decreasing byproduct formation (Nissen *et al*., [@b267], [@b268], [@b269]; Kong *et al*., [@b195], [@b194]; Zhang *et al*., [@b421]).

Stuck or sluggish fermentations are the most commonly encountered reasons for the loss of biofuel yields, especially in very high-gravity conditions. The main causes are shown to be the high osmotic pressure in the first phase of the fermentation, and (even more importantly) the gradually increasing ethanol stress during the fermentation (Gibson *et al*., [@b124]; Puligundla *et al*., [@b303]). In order to tackle this issue, researchers aim at increasing the overall stress tolerance, thereby often increasing yield and/or productivity (see sections 'Mass mating & Genome Shuffling' and 'Enhancing cellular stress tolerance').

Byproduct formation can also significantly lower the yield of biofuel fermentations. The most abundant byproduct of *S. cerevisiae* fermentations is glycerol, which is formed both as an osmolyte to counteract osmotic stress in the first phase of the fermentation (Hohmann, [@b156]) and to convert excess NADH back to NAD^+^ to maintain the redox balance under anaerobic conditions (van Dijken & Scheffers, [@b380]). Typically, glycerol accounts for up to 5% of carbon flux (Oura, [@b280]). Various metabolic engineering strategies have succeeded in reducing glycerol formation, thereby increasing ethanol yield. However, a decrease in growth or fermentation rate (Björkqvist *et al*., [@b33]; Nissen *et al*., [@b268]; Hubmann *et al*., [@b161]) or decreased stress tolerance (Pagliardini *et al*., [@b281]) often hampers industrial applicability of the resulting strains.

### Production of novel compounds

The extensive use and knowledge of the production host *S. cerevisiae* has led to commercial interest in using it to produce advanced biofuels. Because *S. cerevisiae* does not naturally produce most of the advanced biofuels, which include butanol and biodiesel, multiple research groups started to explore metabolic engineering strategies to expand its product range (see for review de Jong *et al*., [@b85]). For instance, a *S. cerevisiae* strain capable of producing fatty acid ethyl esters was created by targeted deletions of genes involved in producing storage lipids and heterologous expression of a bacterial acyltransferase (Kalscheuer *et al*., [@b181]). Multiple studies have explored engineering yeast to produce butanol (e.g. Avalos *et al*., [@b13]). Whereas yeast engineering for advanced biofuels seems promising, more research is needed to allow broad industrial implementation.

### Cellular stress tolerance

During industrial fermentations, yeast cells are confronted with many different stress factors, including heat or cold stress, high osmotic pressure, and high ethanol levels (Gibson *et al*., [@b124]; Puligundla *et al*., [@b303]). With some notable exceptions, targeted metabolic engineering strategies have yielded only limited success in increasing stress tolerance (Larsson *et al*., [@b204]; Gorsich *et al*., [@b134]; Petersson *et al*., [@b295]). One of the most important reasons for this is the fact that stress tolerance is a complex, polygenic trait. A complete picture of the genes and molecular mechanisms underlying these traits is often lacking, which complicates targeted modification. In addition to classical non-GMO techniques, including mutagenesis and experimental evolution, several GMO-based approaches recently succeeded in increasing phenotypic variation in an unbiased fashion, followed by the identification of mutants with increased stress resistance. For instance, Alper *et al*. ([@b9]) used gTME to increase osmotolerance and ethanol tolerance, whereas Park *et al*. ([@b286]) could significantly improve thermotolerance, osmotolerance, or ketoconazole resistance by screening the mutants expressing artificial transcription factors (see section on 'Novel Techniques' below).

Genetic modification of nonconventional yeasts
----------------------------------------------

Although *S. cerevisiae* and closely related species are by far the major producers of biotechnological products worldwide, nonconventional yeasts have been utilized as industrial organisms for a variety of applications (Johnson, [@b177]). Below, a selected overview of the recent progress in genetic modification of key nonconventional yeasts is given.

### *Scheffersomyces* (*Pichia*) *stipitis*

*Scheffersomyces* (*Pichia*) *stipitis* is an ascomycetous yeast extensively studied for its capacity to ferment xylose to ethanol, L-lactic acid, and other products (Johnson, [@b177]). Despite the capacity of *Sc. stipitis* to ferment xylose to ethanol at nearly maximum yield with very limited byproduct formation, few metabolic engineering studies targeting this yeast species have been published (Van Vleet & Jeffries, [@b382]). The main reasons are its respiratory (Crabtree-negative) lifestyle, low ethanol tolerance, and its slow sugar consumption rate compared to *S. cerevisiae* (Agbogbo & Coward-Kelly, [@b4]). Therefore, biotechnological applications involving *Sc. stipitis* are at this point mostly limited to the transfer of its genes to *S. cerevisiae* to introduce the ability to ferment pentose sugars. However, the sequencing of the full genome (Jeffries *et al*., [@b172]) and the development of more efficient transformation systems (e.g. plasmid vectors and a loxP/Cre recombination system) and drug resistance markers (Laplaza *et al*., [@b203]) might create possibilities for genetic modification of industrially applicable *Sc. stipitis* strains. Indeed, recent introduction of the L-lactate dehydrogenase gene from *Lactobacillus helveticus* into *Sc. stipitis* allowed it to efficiently produce L-lactate from xylose-containing medium and illustrates its biotechnological potential (Ilmen *et al*., [@b167]).

### *Yarrowia* (*Candida*) *lipolytica*

*Yarrowia* (*Candida*) *lipolytica* is an ascomycetous yeast that is the teleomorph (spore-forming form) of *C. lipolytica*. With its fully sequenced genome (Dujon *et al*., [@b97]), it is one of the most extensively studied nonconventional yeasts. It is currently used as a model for the study of protein secretion, peroxisome biogenesis, dimorphism, and degradation of hydrophobic substrates (Fickers *et al*., [@b115]). One of its most remarkable features is that it can efficiently use hydrophobic substrates, such as n-alkanes, fatty acids, and oils, as sole carbon source (Fickers *et al*., [@b115]; Beopoulos *et al*., [@b29]), and that it can accumulate lipids to levels exceeding 50% of cell dry weight (Beopoulos *et al*., [@b29]). *Yarrowia* species are mostly known for the production of 'single-cell proteins', but they are currently also used in the production of organic acids (mainly citric acid), aromas (e.g. β-decalactone, 2-phenylethanol), polyols (such as mannitol and erythritol), starters for the food industry, bio-oil, biotransformation of steroids, or waste treatment (Attfield & Bell, [@b12]; Fickers *et al*., [@b115]; Beopoulos *et al*., [@b29]; Guo *et al*., [@b139]; Celinska *et al*., [@b60]; Liu *et al*., [@b222]). Additionally, they are important for the production of certain fermented foods such as blue cheese, where they contribute to the sensorial quality (Gkatzionis *et al*., [@b131]). Because of its nonpathogenic nature*, Y. lipolytica* has received a GRAS (generally regarded as safe) status for these processes (Attfield & Bell, [@b12]), which facilitates further applications of this yeast in food industry.

Although the first publications on genetic recombination in *Y. lipolytica* date back to the early 1970s (Bassel *et al*., [@b21]), the more recently developed molecular and genetic tools to modify *Y. lipolytica* genomes (reviewed by, e.g., Madzak *et al*., [@b236]; Nicaud, [@b264]) and the availability of its complete genome sequence led to promising recent advances in genetic modification of this yeast. For example, higher production of α-ketoglutarate was established by introducing the acetyl-CoA synthetase gene (*ACS1*) from *S. cerevisiae* and the ATP-citrate lyase gene (*ACL*) from *Mus musculus* (Zhou *et al*., [@b430]), or by using a gene dose-dependent overexpression of genes encoding NADP^+^-dependent isocitrate dehydrogenase (*IDP1*) and pyruvate carboxylase (*PYC1*; Yovkova *et al*., [@b416]). Production of β-decalactone, a high-value aromatic compound, was promoted by deleting *POX3* and overexpressing *POX2*, two genes encoding acyl-CoA oxidases with different substrate specificities (Guo *et al*., [@b139]). By introducing codon-optimized genes *crtB* and *crtI* of *Pantoea ananatis* and overexpressing native genes *GGS1* and *HMG1*, a metabolic pathway for lycopene production in the otherwise non-carotenoid-producing *Y. lipolytica* could be established (Matthäus *et al*., [@b244]). Because lipid production of *Y. lipolytica* can be enhanced by the modification of several genes involved in the lipid metabolism (Beopoulos *et al*., [@b31]; Dulermo & Nicaud, [@b98]; Tai & Stephanopoulos, [@b365]; Wang *et al*., [@b400]), additional fine-tuning of the lycopene production pathway could be achieved by deleting *POX1*-6 (thereby cutting short the peroxisomal β-oxidation) and *GUT2* (thereby preventing reduction of the glycerol-3-phosphate pool). This increased the lipid accumulation (and consequently the lycopene yield) significantly and led to the production of 16 mg g^−1^ (dry weight) in fed-batch cultures, the highest yield reported so far for eukaryotic hosts (Matthäus *et al*., [@b244]). Recently, a metabolic engineering approach for the production of ricinoleic acid in *Y. lipolytica* was described (Beopoulos *et al*., [@b30]), describing a yield of 60 mg g^−1^ (dry weight), the most efficient production of ricinoleic acid to date.

### *Kluyveromyces lactis* and *Kluyveromyces marxianus*

*Kluyveromyces lactis* and the closely related *K. marxianus* have been studied for decades and have a well-established track record of safe use in various food industry applications. The genomes of both species are sequenced (Dujon *et al*., [@b97]), and several genetic techniques have been developed for *K. marxianus* (e.g. plasmid vectors; Pecota *et al*., [@b289]; Rocha *et al*., [@b312]; Wang *et al*., [@b400]; or protocols for the integration of linear DNA; Nonklang *et al*., [@b270]) and *K. lactis* (reviewed by van Ooyen *et al.,* [@b381]) in the past 20 years. Historically, *Kluyveromyces* is best known for its production of the bovine milk-clotting enzyme chymosin. This protein was the first heterologous enzyme originating from a higher eukaryote that was produced at low cost in a microorganism. Nowadays, *Kluyveromyces* is used in the production of many heterologous proteins, such as lactase and interleukin 1-b (van Ooyen *et al*., [@b381]).

Other industrially relevant traits of *Kluyveromyces* are its ability to utilize lactose as a primary carbon source (which has applications in the dairy and biofuel industry), and high production of lactate. For this latter application, the central carbon flux of *K. lactis* was diverged from the production of ethanol to enhance lactate production. This was achieved by introducing a heterologous L-lactate dehydrogenase gene (*LDH*) and deleting the unique pyruvate decarboxylase gene *KlPDC1* and/or the pyruvate dehydrogenase (*PDH*) E1 subunit gene (Porro *et al*., [@b299]; Bianchi *et al*., [@b32]). *Kluyveromyces lactis* was recently also proposed a host for L-ascorbic acid (vitamin C) production (Rosa *et al*., [@b316]). In the metabolically engineered strains, GDP-mannose 3,5-epimerase (*GME*), GDP-L-galactose phosphorylase (*VTC2*), and L-galactose-1-phosphate phosphatase (*VTC4*) from *A. thaliana* were introduced.

### *Brettanomyces* (*Dekkera*) *bruxellensis*

*Brettanomyces* (teleomorph: *Dekkera*) is an ascomycetous yeast important in the production of beverages and biofuel. Interestingly, the role of *Brettanomyces* in the food industry is very ambiguous. *Brettanomyces* species, with *B. bruxellensis* as the most important representative, are generally reported as spoilage yeasts. Their off-flavor production in wine, beer, and cider results in huge economic losses. However, more and more authors report that in some cases these yeasts may add positive effects and complexity to, for example, red wines. Additionally, in specialty beers, sour beers, fruit beers, and one Belgian Trappist ale beer, the presence of *Brettanomyces* is required to obtain the characteristic and complex 'Brett flavor', which is (among others) described as clovy, spicy, floral, and/or smoky (Licker *et al*., [@b211]). Although still very premature, the growing interest from industry, the multiple particular phenotypes, the recent (independently performed) sequencing of three complete genomes, the development of an efficient transformation protocol, and the subsequent first transformation of *B. bruxellensis* (Miklenic *et al*., [@b245]) are all hinting toward an upcoming field of *Brettanomyces* engineering. However, more research on efficient and easy-to-use vector systems is still needed.

### *Komagataella* (*Pichia*) *pastoris*

The ascomycetous yeast *Komagataella (P.) pastoris* is mostly known as the prime yeast species for recombinant protein production for both research and industrial purposes. Additionally, it is also a commonly used model organism for methanol assimilation and peroxisomal biogenesis.

*Komagataella pastoris* possesses several characteristics that make it an excellent host for heterologous protein production: its ability to grow to high cell densities, to produce heterologous proteins at very high levels, and to efficiently secrete them and the availability of straightforward procedures used for genetic transformation (although with rather low efficiency). Nevertheless, the amount of efficient genetic engineering tools available was, until recently, rather disproportionate to its industrial potential. The publication of the full genome in 2009 (De Schutter *et al*., [@b86]) provided the information needed to create an extensive toolbox of *Ko. pastoris* expression vectors, which is now commercially available (reviewed by, e.g., Bollok *et al*., [@b38]; Logez *et al*., [@b223]).

Being a methylotrophic yeast, *Ko. pastoris* can utilize methanol as a sole carbon and energy source. This provides a methanol-inducible transgene expression system, where the target protein gene is usually put under control of the strongly inducible promoter of the alcohol oxidase 1 (*AOX1*) gene (Cereghino & Cregg, [@b61]). *Komagataella pastoris* has already been used to produce over 500 different heterologous proteins (see Johnson, [@b177]; reviewed by Cereghino & Cregg, [@b61]; Macauley-Patrick *et al*., [@b233]). For example, the efficient biosynthesis of high-value carotenoids, such as lycopene \[1.141 μg g^−1^ (dry weight)\] and β-carotene \[339 μg g^−1^ (dry weight)\], was recently described in *Ko. pastoris* (Araya-Garay *et al*., [@b11]). Three carotenogenic enzymes were expressed for the production of lycopene, geranylgeranyl diphosphate synthase (crtE), phytoene synthase (crtB), and phytoene desaturase (crtI) from *Erwinia uredovora*. To convert lycopene into β-carotene, another gene encoding a lycopene β-cyclase (crtL) from *Ficus carica* was additionally expressed. Another example is the production of laccase (4.85 mg L^−1^) by *Ko. pastoris* by expressing the *lac4* gene of *Pleurotus sajor-caju* (Soden *et al*., [@b350]). Additionally, several studies describe the genetic modification of the glycosylation pathway in *Ko. pastoris*, enabling these strains to produce complex, mammalian- and human-type N-glycans (e.g. Vervecken *et al*., [@b389]), such as functional recombinant erythropoietin (Hamilton *et al*., [@b142]).

### Schizosaccharomyces pombe

*Schizosaccharomyces pombe*, also called 'fission yeast', is mostly known as a model organism for both molecular and cell biology. For example, the mechanisms of signal transduction and cell cycle regulation in eukaryotic cells (research on the latter resulted in 2001 in a 'Nobel Prize in Physiology or Medicine' for Sir Paul Nurse) were elucidated using *Sc. pombe* (Giga-Hama & Kumagai, [@b127]). The genome of *Sc. pombe*, published in 2002, was the second unicellular eukaryotic genome to be fully sequenced and the sixth eukaryotic organism overall (Wood *et al*., [@b407]).

The potential of this well-characterized yeast species as an expression tool for heterologous proteins has already been known for a long time (reviewed, e.g., by Takegawa *et al*., [@b366]). Because of the intensive use of *Sc. pombe* in both fundamental and applied research, numerous papers describe the use of (integration-type) plasmids for molecular manipulation (reviewed by Siam *et al*., [@b344]; more recent studies by Erler *et al*., [@b111]; Chino *et al*., [@b64]; Terazawa *et al*., [@b370]; Verma & Singh, [@b384]). Interestingly, notwithstanding the vast phylogenetic distance separating the two species, transformation protocols from *S. cerevisiae* can usually be used in *Sc. pombe* (Okazaki *et al*., [@b273]).

*Schizosaccharomyces pombe* has been used as a host for the production of many different heterologous proteins. For example, the introduction of the *E. coli* B phytase-encoding gene (*appA*) *in Sc. pombe* led to the expression of a secreted, glycosylated phytase, intended for use in animal feed (Ciofalo *et al*., [@b69]). Another industrially relevant example is the efficient production of vanillin (65 mg L^−1^), the main constituent of vanilla flavor and worldwide one of the most important flavor compounds (Hansen *et al*., [@b147]). By introducing three heterologous genes (a 3-dehydroshikimate dehydratase from *Podospora pauciseta*, an aromatic carboxylic acid reductase from *Nocardia* sp., and a human *O*-methyltransferase), Holic *et al*. ([@b157]) established a new biosynthetic pathway with glucose as the primary metabolite. By knocking out the *Sc. pombe* alcohol dehydrogenase *ADH6*, the reduction of vanillin to vanillyl alcohol was blocked. In 2012, the introduction of a *Claviceps purpurea* oleate Δ12-hydroxylase gene (*FAH12*) led to the production at high concentrations (137 mg mL^−1^) of ricinoleic acid (Holic *et al*., [@b157]). Furthermore, the physiology of *Sc. pombe* (such as its cell cycle, chromosome structure, and RNA splicing) often shows a high similarity to more complex eukaryotic cells and can therefore be used to express heterologous genes from higher eukaryotes (Giga-Hama *et al*., [@b128]; Ikeda *et al*., [@b166]). However, for heterologous expression of most high eukaryotic genes, *Ko. pastoris* is still considered the best expression system (cf. supra).

Novel techniques and future perspectives
----------------------------------------

Genetic modifications as well as non-GMO approaches such as hybridization, mutagenesis, and directed evolution approaches have contributed to the expansion of strains (potentially) useful for industrial purposes. However, as discussed above, each of these techniques has its shortcomings and limitations. In short, non-GMO techniques are often limited to phenotypes that allow efficient selection, and they often involve a risk of improving one property at the expense of others. GMO techniques, on the other hand, require in-depth knowledge of the underlying genetics and are in many cases not well received by consumers. The ever-growing knowledge of yeast physiology and the continuously expanding biotechnological toolbox now allow more adventurous techniques using recombinant DNA technologies to emerge, which target (and sometimes overcome) some of the drawbacks mentioned above. Interestingly, several of these novel techniques combine aspects of both classic non-GMO techniques and genetic modification. Here, we highlight some of these techniques that could either be an alternative or complementary to these well-established approaches (Fig.[5](#fig05){ref-type="fig"}). It should be noted though that most of these techniques still need to prove their usefulness to generate commercially applicable yeast strains.

![Novel techniques for genetic modification of industrial strains. Schematic overview of selected techniques to generate phenotypic diversity in (industrial) *S. cerevisiae* strains. The wild-type situation is always shown on the left, and the altered situation on the right. The thickness of the arrows indicates the transcription level of the genes. Global techniques (a--c) include global transcription machinery engineering (a), which exploits genome-wide transcriptional re-wiring generated by a mutated general transcription factor; artificial zinc finger transcription factors (b), creating altered transcription profiles resulting from transcription factors with a wide variety of specificity, for instance by coupling randomized zinc fingers to a repression domain; and transposon mutagenesis (c), which knocks out genes in a random fashion. Targeted techniques comprise *in vitro* generation of genetic variability using random mutagenesis (d) or DNA shuffling (e), TaGTEAM (f), which can drastically elevate the local mutation rate by targeting a mutator protein (=DNA glycosylase + DNA-binding protein) to a specific genomic region, and the use of oligonucleotide-based approaches like synthetic oligonucleotides (g) to introduce specific gene deletions or mutations. See text for more details.](fmr0038-0947-f5){#fig05}

### gTME

Because complex phenotypes are determined by a large number of genes, Alper *et al*. ([@b9]) hypothesized that huge phenotypic variation could be realized and exploited by (randomly) reprogramming transcription followed by selection of those variants that show improved properties. To this end, they developed a method termed 'global transcription machinery engineering' (gTME), which is based on creating a library of randomly mutated versions of a global transcription factor or associated factor. This library is then introduced in the strain of interest, creating a pool of mutants with different mutations in the gene encoding the transcription factor, followed by a screening (as discussed in the section on 'Selection of phenotypically improved cells') to identify mutants showing substantial phenotypic improvement. As a proof-of-principle, they created a mutant library of the TATA-binding protein which was transformed into a laboratory yeast strain. Interestingly, strains could be recovered showing increased glucose and ethanol tolerance and improved fermentation capacity (Alper *et al*., [@b9]). A later study pointed out that this phenotypic improvement could be explained by fixing a defect in leucine uptake and/or utilization present in the laboratory strain and could only be reproduced in medium with low amounts of leucine (Baerends *et al*., [@b15]). Therefore, other studies are needed to confirm the usefulness of this approach to obtain industrial yeasts with increased stress tolerance.

### Coupling of zinc fingers with transcription factors

Another approach exploiting global transcriptional variation uses combinatorial libraries of zinc finger-containing proteins (Park *et al*., [@b286]). Many zinc fingers are highly specific DNA-binding structural motifs, stabilized by a zinc atom, present in many transcriptional regulators. Each zinc finger binds a specific DNA sequence of three base pairs, and the exact number and configuration of zinc fingers of a transcription factor determines its specificity. In practice, a large library of artificial transcription factors consisting of random combinations of three or four zinc fingers coupled to either an activation or repression domain is generated. Next, plasmids harboring the genes coding for these proteins are transformed in the target strain, after which a screening for the phenotype of interest takes place to select superior variants. When these artificially generated transcription factors were transformed into yeast, the authors were able to obtain cells with increased thermotolerance, osmotolerance, or ketoconazole resistance (Park *et al*., [@b286]).

### Transposon mutagenesis

Transposon mutagenesis is a technique to introduce gene knockouts in a random fashion to generate variability in a yeast population. In brief, drug resistance cassettes are randomly inserted into the genome by transposition, after which the obtained collection of mutants is screened for superior variants (Hamer *et al*., [@b141]). When a mutant of interest is found after screening, a PCR-based sequencing reaction can pinpoint the targeted genomic region. This is an important advantage compared to classical mutagenesis, where it is difficult to map the genetic changes underlying an improved phenotype. Using this technique, researchers were able to identify genes involved in thermo- and ethanol tolerance (Kim *et al*., [@b186]).

### *In vitro* generation of genetic variability: random mutagenesis

Although *in vivo* random mutagenesis (see 'Generation of artificial diversity') is a well-established and often powerful technique, the simplicity and more 'targeted' characteristics of *in vitro* mutagenesis of genetic material makes it often the preferred approach to generate variability. To this end, several different techniques have been developed, such as several InDel mutagenesis techniques and sequence saturation mutagenesis (SeSaM). This is particularly useful when the active site of an enzyme is known, but the most optimal combinations of amino acids not. For instance, Young *et al*. ([@b414]) identified a conserved motif present in transporters that prefer xylose over glucose, and by applying SeSaM on the variable residues in this motif, they could modify primary hexose transporters into xylose transporters. However, the most widespread is the use of error-prone PCR (epPCR; Nair & Zhao, [@b257]). Typically, the gene of interest, or alternatively promoter regions or even whole genomes, is subjected to PCR amplification with an elevated error rate (by the lack of exonuclease activity and/or nonideal reaction conditions), followed by transformation of the fragments into the microorganism of interest and a screening to recover mutants that display phenotypic improvement. For instance, Runquist *et al*. ([@b323]) applied epPCR to the cofactor-binding region of the *Sc. stipitis* gene *XYL1*, one of the enzymes needed for *S. cerevisiae* to consume xylose, and transformed this library into *S. cerevisiae*. After repeated rounds of selection in xylose medium, a strain with increased ethanol productivity could be isolated and two causative mutations in the mutagenized region were identified. Similarly, the epPCR-mediated mutation of the xylose isomerase gene (*xylA*) from *Piromyces sp*. and subsequent transformation of the library into *S. cerevisiae* yielded the identification of significantly improved enzyme variants (Lee *et al*., [@b206]). Recently, two reports on the directed evolution by epPCR of multiple genes in the cellobiose utilization pathway (β-glucosidase and the cellodextrin transporter) for efficient biofuel production were published (Eriksen *et al*., [@b110]; Yuan & Zhao, [@b417]). EpPCR can also be applied on promoters (e.g. the promoter of *TEF1* (*S. cerevisiae*) or *GAP* (*Ko. pastoris*), cf. supra) or the whole genome. This latter approach was, for example, used to improve ethanol tolerance of *S. cerevisiae* (Luhe *et al*., [@b231]).

Apart from being directly used as a gene improvement method, epPCR of a general transcription factor is the first step in global transcription machinery engineering (cf. supra).

### *In vitro* generation of genetic variability: DNA shuffling

Another way of generating artificial genetic diversity in a protein or pathway *in vitro* is by DNA shuffling (Stemmer, [@b358]). In contrast to diversification with random mutagenesis, such as methods using epPCR, DNA shuffling exploits the recombination between genes. The technique was initially proposed in 1994 and often referred to as 'sexual PCR'. Its original setup involves three steps. First, a heterogeneous pool of closely related genes (or mutagenized copies or different alleles of the same gene) is enzymatically digested by DNase I to generate smaller fragments of DNA. Next, a primer-free PCR allows the small fragments to cross-prime each other for replication, in order to create longer fragments, resulting in hybrid DNA strands with genetic material from multiple parents. Ultimately, the recombined genes are amplified by PCR using specifically designed primers that only target full-length genes, which can subsequently be screened (Bacher *et al*., [@b14]).

Today, numerous variants of classical DNA shuffling have been described. However interesting, the numerous techniques developed to improve protein function by gene recombination are only briefly discussed below, but are discussed extensively elsewhere (Nair & Zhao, [@b257]). For example, 'restriction enzyme-based shuffling' (Kikuchi *et al*., [@b185]), 'staggered extension progress' (StEP; Zhao *et al*., [@b425]), 'random priming recombination' (Shao *et al*., [@b341]), and 'random chimeragenesis on transient templates' (RACHITT; Coco *et al*., [@b71]) all rely on the same general principle as 'sexual PCR', yet with some adaptations to overcome specific drawbacks. Alternatively, oligonucleotide-based approaches, such as 'synthetic shuffling', can be applied when the sequence of the parental genes is known and when they have adequate sequence identity (Ness *et al*., [@b260]). In this setup, degenerate oligonucleotides are used to construct functional libraries. All these techniques described above rely (much like 'sexual PCR' itself) on homologous recombination. Other methods, such as 'incremental truncation for the creation of hybrid enzymes' (ITCHY; Ostermeier *et al*., [@b277]), 'sequence homology-independent protein recombination' (SHIPREC; Sieber *et al*., [@b346]), and 'Golden gate shuffling' (Engler *et al*., [@b108]), use nonhomologous recombination for shuffling.

*Saccharomyces cerevisiae* is often used as the *in vivo* model to screen the created library, or sometimes even to further improve diversity by additional DNA shuffling (an approach called 'combinatorial libraries enhanced by recombination in yeast', CLERY; Abecassis *et al*., [@b2]), but direct use of DNA shuffling for the improvement of industrial yeast strains has not been described so far.

### TaGTEAM

In many cases, it is clear which genes are responsible for a certain property, but it is less clear which exact mutations would result in improvements. In this case, it can be valuable to specifically increase the mutation rate in a targeted region of the genome. To this end, Finney-Manchester & Maheshri ([@b116]) developed a method termed 'targeting glycosylases to embedded arrays for mutagenesis (TaGTEAM)'. In short, a DNA glycosylase is fused to a DNA-binding protein, and the corresponding binding sites are inserted close to the region of interest. As a result, the mutation rate will locally be elevated more than 800-fold. A possible application of this technology is to move a set of genes (for instance, encoding a biochemical pathway or genes involved in a type of stress resistance) into the genomic region showing elevated mutation rates, followed by evolutionary engineering. As such, chances of developing improved mutants are expected to increase, while minimizing the risk of changing other strain properties.

### Synthetic oligonucleotides

Various oligonucleotide-based approaches have been developed to introduce genetic alterations without leaving any traces. Moerschell *et al*. ([@b248]) developed a technique in which transformation of yeasts with synthetic oligonucleotides as short as 20 nucleotides can be employed for site-specific mutagenesis. However, because no selectable markers are involved, this kind of genetic alteration is only applicable to selectable phenotypes. Alternatively, several methods make use of a selectable and/or counter-selectable marker in order to introduce desired genetic changes. Erdeniz *et al*. ([@b109]) described cloning-free PCR-based allele replacement methods in which either alternative alleles or *de novo* mutations can be introduced. Through a series of PCRs of both the allele to be inserted and a marker gene (for instance, *URA3*) and co-transformation of these fragments, the original allele will (after integration) be replaced by a duplication of the novel gene with a *URA3* gene in between these two copies. After selection for direct repeat recombinants (pop-out of the marker), only a single copy of the new allele remains. Similarly, the *delitto perfetto* approach is a two-step cloning-free technique to introduce site-specific genetic alterations or specific deletions up to 200 base pairs. The first step comprises the insertion of a 'CORE' (counter-selectable reporter) cassette in the region of interest. In the second step, integrative recombinant oligonucleotides, harboring homologous sequences flanking the CORE cassette are introduced, which mediate removal of the CORE cassette while simultaneously inserting the mutation or deletion (Storici *et al*., [@b362]).

Discussion -- The new GM techniques bridge the gap between classic breeding and genetic modification
----------------------------------------------------------------------------------------------------

Since its first successful application in 1973, recombinant DNA technology has proven to harbor an enormous potential for strain improvement. While initial approaches only focused on single genes, methodologies such as metabolic engineering and inverse metabolic engineering target complete pathways, resulting in more efficient phenotypic improvements. Moreover, recent technological advances allow other methods, such as TaGTEAM and gTME, to generate 'semi-random' diversity, where an enormous number of different mutations can be introduced in a specific genomic region, thereby limiting the risk of off-target deleterious mutations that result in crippled strains. Therefore, these approaches can provide a valuable alternative for (or can be complementary to) the 'non-GMO' strain improvement approaches, such as mutagenesis, hybridization, or evolutionary engineering, discussed in 'Discussion -- pros and cons of exploiting natural and artificial diversity'.

However, the major disadvantage of these techniques remains the classification of the resulting strains as GMOs, impeding some industrial applications. Interestingly, strains engineered via 'self-cloning' do not have a GMO status in some countries, for example Japan (Akada, [@b5]). Self-cloning is defined as genetic modification where no DNA from another species is introduced into the genome. Therefore, the use of self-cloning principles may help to obtain formal approval to use the strain for production purposes.

Conclusion
==========

Both traditional and novel yeast-based industries can benefit from using superior yeasts that yield increased production efficiency and/or product quality. Significant progress has already been made by exploring the existing natural diversity, by creating artificial diversity and combining beneficial traits of different strains using hybridization, as well as by targeting specific traits through genetic modification. However, the new knowledge and technologies summarized above show that there are still enormous opportunities to obtain superior industrial yeasts. However, important challenges also still remain.

Firstly, the currently used industrial strains represent only the tip of the proverbial iceberg of the actual genetic diversity present in nature. More extensive genotyping and phenotyping of both natural isolates and nonconventional yeasts will help to identify strains and species with novel and/or improved industrially important properties.

Secondly, although the genetics and physiology of laboratory yeast strains are well characterized, our knowledge about industrial strains is lagging behind. The complex genetic make-up of these strains (which are often polyploid, alloploid, and/or aneuploid) has hampered genetic studies and strain improvement strategies. Importantly, recent studies report the sequencing of industrial strains in their natural ploidy, increasing insight into their genetic architecture.

Thirdly, many industrially relevant phenotypes have a complex genetic base and depend on a large number of genes, scattered throughout the genome. Dissecting these complex traits at the genetic level is currently one of the biggest challenges in molecular biology. The advent of next-generation sequencing technologies allows for fast generation of full-genome sequences at a relatively low cost. Together with large-scale phenotyping approaches, this enables researchers to start mapping the causative mutations for complex industrially relevant traits, such as ethanol tolerance. These approaches not only generate insight into complex phenotypes, but the obtained knowledge can also be used to directly modify strains by inserting only the causative mutation(s). Additionally, novel techniques such as genome shuffling use the existing diversity to a much greater extent and can enhance complex phenotypes much more rapidly compared to more classical approaches of strain improvement. An in-depth study of hybrids generated through this approach could potentially yield insight into the genetics underlying improved phenotypes as well.

Fourthly, it is clear that genetic modification can be a valuable approach to enhance phenotypes for which the causative mutations are known. In spite of this, legislation issues and negative consumer\'s perception of the use of GMOs in the food chain often hamper industrial application and success of such GM strains. It remains to be seen whether (and how) regulations and public perception will change in the future.

The prospects to obtain superior industrial yeasts are extremely bright. Yeasts offer unique advantages for strain improvement: they combine sexual and asexual life cycles, they can be cultivated in high numbers, and genetic transformation is often easy. Moreover, the examples discussed in this review illustrate that most strain improvement strategies are not mutually exclusive, but can be combined to create even more variation. Additionally, by combining different techniques, the drawbacks of a specific technique can be circumvented. For example, combining random mutagenesis with multiple rounds of genome shuffling is a promising approach to both recombine useful mutations and lose deleterious mutations. Moreover, further development and optimization of current approaches and newly emerging technologies such as next-generation sequencing, combined with a better understanding of complex phenotypes and nonconventional yeasts, pave the way to obtain yeasts that are even better adapted to their industrial tasks.
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